data_5ujg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ujg _Structure_validation_residue.Date_analyzed 2018-01-19 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.652 0.739 . . . . 73.209999999999994 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -40.57 5.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 75.329999999999998 112.335 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.11 160.56 2.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.595 0.712 . . . . 65.540000000000006 110.854 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -44.05 2.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.687 2.258 . . . . 74.310000000000002 112.389 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.31 133.23 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 111.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.24 125.9 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 72.519999999999996 110.935 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -84.16 -36.04 23.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.169 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.45 179.71 4.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.875 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -66.76 160.63 67.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 71.450000000000003 110.888 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 157.07 61.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 73.239999999999995 112.305 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.57 3.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 62.0 112.49 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -64.62 140.34 58.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 74.319999999999993 110.922 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -87.73 144.55 26.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 75.530000000000001 111.09 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.99 127.53 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 65.230000000000004 110.888 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -120.8 141.98 50.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -99.56 35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.5 -81.43 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.762 . . . . 61.140000000000001 112.47 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -51.91 164.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.793 0.33 . . . . 74.030000000000001 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -51.23 -35.43 36.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 72.409999999999997 110.852 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.05 140.42 15.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 63.100000000000001 112.508 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -51.83 126.24 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 71.430000000000007 110.985 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.2 175.52 20.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 73.140000000000001 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.36 115.34 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 63.229999999999997 110.904 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.099999999999994 110.836 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.629 0.728 . . . . 74.310000000000002 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 91.67 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.664 2.243 . . . . 72.540000000000006 112.364 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -133.47 160.58 68.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.591 0.71 . . . . 62.210000000000001 110.917 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -44.94 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.728 2.285 . . . . 72.109999999999999 112.337 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.05 134.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.122 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -90.64 142.51 27.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.489 . . . . 73.430000000000007 110.932 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -110.02 -64.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 111.152 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 m -81.74 179.2 7.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 75.239999999999995 110.839 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -77.5 160.6 74.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 74.450000000000003 110.861 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.94 51.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 74.439999999999998 112.359 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -49.59 3.91 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 73.5 112.455 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -65.12 149.57 49.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 74.299999999999997 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -90.39 137.05 32.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 75.450000000000003 111.165 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.1 127.92 35.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.9 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -123.87 149.98 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.62 38.49 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.019999999999996 110.894 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.33 -64.59 2.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.732 -0.746 . . . . 61.210000000000001 112.49 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.97 164.73 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.899 0.381 . . . . 74.409999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -51.18 -35.38 35.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 110.869 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.53 138.43 14.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 72.230000000000004 112.492 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.0 127.79 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 74.510000000000005 110.931 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.99 175.4 27.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.756 -0.735 . . . . 75.540000000000006 112.508 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 p -112.63 127.62 56.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 74.219999999999999 110.879 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.400000000000006 110.887 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 73.439999999999998 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 145.16 56.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.255 . . . . 71.109999999999999 112.323 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.27 160.08 1.18 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 74.310000000000002 110.85 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -43.33 2.7 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.678 2.252 . . . . 65.340000000000003 112.334 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.06 149.18 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.095 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -72.06 114.96 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 64.209999999999994 110.936 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -70.24 177.71 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 75.239999999999995 111.138 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.0 m -70.94 -175.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 61.310000000000002 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -61.4 160.6 23.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.573 0.701 . . . . 75.530000000000001 110.904 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 169.58 18.54 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.725 2.283 . . . . 72.530000000000001 112.373 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -50.35 4.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 61.100000000000001 112.512 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.96 151.59 45.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 74.409999999999997 110.946 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 t -82.87 143.87 30.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t -94.04 148.12 22.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.851 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.2 p -130.49 141.78 50.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.430000000000007 110.91 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -111.1 37.74 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 -77.75 0.54 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.725 -0.75 . . . . 62.219999999999999 112.491 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -51.95 164.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 74.120000000000005 110.893 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -51.97 -35.92 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 74.510000000000005 110.873 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.95 138.7 14.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 71.030000000000001 112.509 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -52.91 132.36 37.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 73.340000000000003 110.913 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.82 170.19 25.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 72.150000000000006 112.499 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.6 p -99.19 140.52 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 71.540000000000006 110.889 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 65.230000000000004 110.822 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.624 0.726 . . . . 71.319999999999993 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -33.23 17.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.662 2.241 . . . . 72.200000000000003 112.343 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.97 160.59 1.12 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 75.450000000000003 110.919 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -33.12 17.26 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.725 2.283 . . . . 71.319999999999993 112.327 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -55.36 121.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 65.140000000000001 111.095 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.5 123.68 49.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 110.912 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -100.96 -37.99 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.349999999999994 111.144 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -120.8 175.11 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.340000000000003 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -63.35 159.1 52.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.741 . . . . 74.329999999999998 110.85 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 167.9 23.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.654 2.236 . . . . 72.239999999999995 112.346 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.51 -51.31 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 60.020000000000003 112.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.67 144.62 57.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 64.439999999999998 110.89 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -82.29 144.56 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 71.230000000000004 111.166 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.55 117.92 27.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 73.109999999999999 110.918 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.1 p -98.92 139.35 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.549999999999997 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -100.31 35.74 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.41 -82.65 0.16 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 73.140000000000001 112.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.4 mt -51.88 164.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 64.230000000000004 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -51.47 -35.5 40.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.099999999999994 110.864 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.63 140.79 15.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 74.420000000000002 112.469 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -52.0 125.0 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 75.239999999999995 110.951 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.3 175.47 20.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.319999999999993 112.496 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -106.57 132.73 52.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 63.530000000000001 110.85 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 71.519999999999996 110.883 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.616 0.722 . . . . 71.540000000000006 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 82.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.25 . . . . 75.400000000000006 112.355 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.0 160.52 30.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 73.519999999999996 110.87 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -48.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.723 2.282 . . . . 72.209999999999994 112.335 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.49 150.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.219999999999999 111.133 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.0 107.92 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 110.912 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -96.81 -37.26 10.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 63.130000000000003 111.144 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.3 m -106.73 179.5 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 74.409999999999997 110.879 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -97.83 160.54 28.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 61.140000000000001 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 163.38 38.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 71.230000000000004 112.388 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -49.45 3.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 71.310000000000002 112.492 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -65.55 136.1 55.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 71.519999999999996 110.919 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -83.01 139.84 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 63.530000000000001 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -79.43 114.21 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 75.510000000000005 110.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.32 143.84 27.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.885 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -103.98 38.85 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.859 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.47 -82.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.329999999999998 112.486 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -51.88 164.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 65.209999999999994 110.949 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -51.57 -35.62 41.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.827 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.2 138.64 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 71.409999999999997 112.479 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -51.96 123.32 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 73.439999999999998 110.924 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.22 175.51 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 75.400000000000006 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 p -114.69 121.02 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 74.239999999999995 110.858 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.912 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.627 0.727 . . . . 71.109999999999999 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 95.89 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.701 2.268 . . . . 72.129999999999995 112.328 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.54 160.04 1.11 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.568 0.699 . . . . 72.530000000000001 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -48.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.246 . . . . 72.450000000000003 112.317 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -101.51 150.14 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.549999999999997 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -97.62 160.47 14.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.019999999999996 110.918 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -118.18 -66.11 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 64.109999999999999 111.138 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 m -60.85 -179.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.140000000000001 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -74.09 160.56 81.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 73.239999999999995 110.85 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 159.31 53.9 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.702 2.268 . . . . 74.010000000000005 112.304 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.02 -51.27 4.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.432 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.59 128.76 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 61.439999999999998 110.899 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -81.51 144.7 31.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 111.12 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -83.89 119.02 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 110.918 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 p -106.66 153.75 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.854 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 35.74 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 110.831 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.1 -74.26 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 72.140000000000001 112.47 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.09 164.59 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 75.430000000000007 110.932 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -51.54 -35.65 41.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.874 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.25 138.51 14.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 70.129999999999995 112.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -52.01 130.57 30.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 74.439999999999998 110.899 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.08 175.49 30.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 65.340000000000003 112.49 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -106.14 134.42 49.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 73.310000000000002 110.933 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 110.887 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.612 0.72 . . . . 63.219999999999999 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.01 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.634 2.222 . . . . 74.430000000000007 112.373 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.54 158.53 1.46 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.576 0.703 . . . . 74.319999999999993 110.87 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 -34.6 13.84 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.65 2.233 . . . . 64.239999999999995 112.339 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.2 120.43 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.409999999999997 111.102 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.76 163.12 14.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 75.549999999999997 110.974 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -123.88 -57.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.019999999999996 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.5 174.78 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.120000000000005 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.17 160.53 78.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.581 0.705 . . . . 72.409999999999997 110.872 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 170.17 17.16 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.669 2.246 . . . . 74.340000000000003 112.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.56 -51.51 4.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.738 . . . . 71.239999999999995 112.505 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -64.83 147.68 52.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 70.540000000000006 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 p -83.66 143.34 30.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 111.137 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t -87.24 149.7 24.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -135.48 138.74 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.230000000000004 110.896 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 ttp85 -105.09 37.79 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.889 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.98 -78.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 71.239999999999995 112.481 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.5 mt -52.56 164.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 62.149999999999999 110.912 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -35.72 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.420000000000002 110.868 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.59 140.65 15.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.481 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -52.02 123.91 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 75.540000000000006 110.926 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.62 171.77 21.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.713 -0.756 . . . . 62.240000000000002 112.48 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -105.71 129.59 53.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 73.510000000000005 110.861 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.89 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.686 0.755 . . . . 74.109999999999999 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 84.68 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 74.430000000000007 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -114.31 73.43 2.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.732 . . . . 73.209999999999994 110.879 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -33.15 17.28 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 73.239999999999995 112.352 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -67.6 146.59 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.319999999999993 111.117 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.14 98.13 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.925 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.33 -51.19 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 64.129999999999995 111.162 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.57 171.44 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 51.530000000000001 110.837 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -91.06 159.01 40.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.624 0.726 . . . . 63.43 110.854 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.52 16.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.652 2.235 . . . . 74.209999999999994 112.326 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.46 -49.5 3.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 71.219999999999999 112.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.66 144.71 57.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.439999999999998 110.892 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -84.51 144.71 28.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.420000000000002 111.146 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.5 t -79.33 140.98 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 72.5 110.834 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 p -119.45 147.45 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 72.209999999999994 110.88 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -102.03 133.75 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.886 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.89 -89.44 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 71.019999999999996 112.477 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.02 165.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.420000000000002 110.896 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -49.12 -34.26 13.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.66 149.97 17.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.696 -0.764 . . . . 75.230000000000004 112.491 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -51.55 132.69 30.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 75.439999999999998 110.911 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.4 165.63 12.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.69 -0.767 . . . . 72.439999999999998 112.478 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.6 p -120.06 113.02 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.25 110.921 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 110.879 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.643 0.735 . . . . 72.420000000000002 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -46.43 1.26 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.385 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -145.44 68.44 13.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 74.409999999999997 110.865 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 176.5 6.68 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.655 2.236 . . . . 74.549999999999997 112.388 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.66 147.06 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 73.519999999999996 111.161 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.35 98.16 8.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.948 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -135.77 -41.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 75.430000000000007 111.106 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.04 -179.86 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 74.150000000000006 110.858 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -95.29 159.3 33.14 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.565 0.697 . . . . 73.319999999999993 110.878 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 163.07 39.66 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.688 2.259 . . . . 75.209999999999994 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -45.8 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 71.150000000000006 112.48 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.18 144.54 57.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 74.430000000000007 110.923 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -94.2 144.94 25.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 62.030000000000001 111.178 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 t -79.17 133.2 36.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.140000000000001 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.99 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.409999999999997 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttp85 -102.6 41.81 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 75.209999999999994 110.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.57 -78.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 71.25 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.77 165.14 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 74.340000000000003 110.883 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -49.8 -34.55 19.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 61.350000000000001 110.837 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.43 141.51 15.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 62.229999999999997 112.483 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.67 126.36 17.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.944 0.402 . . . . 75.409999999999997 110.88 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.06 167.56 18.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 65.129999999999995 112.463 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 p -121.52 119.72 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 64.109999999999999 110.875 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.549999999999997 110.883 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.688 0.756 . . . . 72.140000000000001 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 133.93 26.93 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 75.319999999999993 112.357 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.61 160.14 48.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 73.409999999999997 110.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -39.9 5.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 73.420000000000002 112.33 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.82 112.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.540000000000006 111.101 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -84.93 100.53 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 73.519999999999996 110.922 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -125.86 -42.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 75.329999999999998 111.154 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.57 178.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.867 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.85 157.61 59.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.578 0.704 . . . . 74.310000000000002 110.877 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 162.57 41.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.33 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.59 3.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 65.329999999999998 112.483 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -64.67 143.53 57.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.878 0.371 . . . . 74.329999999999998 110.907 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 t -83.79 139.18 32.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.12 136.67 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.400000000000006 110.855 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.06 151.33 50.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.030000000000001 110.892 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 37.06 3.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 110.862 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.84 -82.56 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 63.25 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 164.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.375 . . . . 73.349999999999994 110.9 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -50.45 -34.96 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.230000000000004 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.14 142.14 15.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.667 -0.778 . . . . 72.430000000000007 112.458 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.55 133.9 52.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 74.329999999999998 110.954 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.91 175.44 29.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 73.099999999999994 112.464 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.0 p -114.98 122.02 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 70.519999999999996 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 110.86 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.629 0.728 . . . . 74.329999999999998 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -33.58 16.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.64 2.226 . . . . 74.400000000000006 112.325 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.02 160.52 78.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 61.509999999999998 110.839 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -42.48 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.236 . . . . 75.319999999999993 112.312 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.41 145.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 70.439999999999998 111.095 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -129.73 104.75 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 72.329999999999998 110.923 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -111.33 -35.78 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 72.109999999999999 111.128 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.36 168.56 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 63.520000000000003 110.935 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -83.85 159.15 61.01 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.71 . . . . 74.439999999999998 110.892 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 169.77 18.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 74.340000000000003 112.323 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.56 -50.29 4.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 62.520000000000003 112.53 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -64.66 152.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 71.450000000000003 110.92 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 t -88.59 144.63 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 111.11 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.73 132.77 34.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 62.100000000000001 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.9 p -113.29 143.85 43.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.010000000000005 110.887 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -110.34 51.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.825 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.08 -78.74 1.15 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 64.310000000000002 112.484 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -51.62 165.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 74.040000000000006 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -49.07 -34.27 13.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 75.329999999999998 110.85 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.51 -172.25 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 60.240000000000002 112.485 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -89.69 127.7 35.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 72.439999999999998 110.902 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.24 175.35 19.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 72.299999999999997 112.458 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 p -119.14 124.71 47.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.367 . . . . 63.140000000000001 110.852 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.239999999999995 110.838 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.666 0.746 . . . . 65.5 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -37.53 9.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.252 . . . . 72.439999999999998 112.376 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.21 68.16 0.2 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 64.209999999999994 110.834 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 73.310000000000002 112.364 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.26 150.22 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.530000000000001 111.142 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 98.1 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.94 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.53 -52.89 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 63.310000000000002 111.105 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 m -67.49 169.74 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 62.340000000000003 110.878 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 155.86 67.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 73.340000000000003 110.909 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 155.95 64.46 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.722 2.282 . . . . 73.140000000000001 112.317 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.54 -48.89 3.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 71.420000000000002 112.511 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.45 129.93 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 110.899 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -85.82 144.78 27.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.340000000000003 111.148 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -79.25 131.9 36.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 64.349999999999994 110.907 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.11 153.78 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 110.862 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -107.92 40.58 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.099999999999994 110.836 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.28 -81.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 72.329999999999998 112.471 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.86 164.84 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 75.219999999999999 110.86 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -50.73 -35.12 29.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 73.299999999999997 110.894 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.39 144.69 15.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 63.509999999999998 112.483 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -51.86 127.39 20.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 70.129999999999995 110.938 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.93 175.54 21.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 71.219999999999999 112.491 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.83 123.32 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 70.209999999999994 110.893 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.540000000000006 110.865 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.609 0.719 . . . . 62.229999999999997 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.259 . . . . 65.340000000000003 112.356 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -117.65 68.68 6.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 71.120000000000005 110.857 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 64.129999999999995 112.351 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.91 149.89 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 111.092 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.11 98.4 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 110.933 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -130.55 -49.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 73.150000000000006 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.21 -174.36 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 157.61 50.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 73.239999999999995 110.854 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.89 26.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 71.030000000000001 112.319 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 -49.85 4.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 61.009999999999998 112.49 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -64.84 144.95 56.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.914 0.388 . . . . 74.510000000000005 110.861 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -85.19 144.57 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.230000000000004 111.151 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -79.38 140.42 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.861 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.17 138.65 51.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.891 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -109.9 54.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.904 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.76 1.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 52.420000000000002 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.6 165.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 74.430000000000007 110.937 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -49.41 -34.47 16.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.828 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.17 -174.77 31.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 73.209999999999994 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.7 129.41 36.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.925 0.393 . . . . 75.329999999999998 110.909 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.22 168.7 20.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 72.040000000000006 112.525 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -117.86 115.59 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 72.150000000000006 110.905 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 54.219999999999999 110.871 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.651 0.738 . . . . 54.140000000000001 110.859 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -33.43 16.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.727 2.285 . . . . 65.340000000000003 112.314 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.99 160.49 1.15 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.644 0.735 . . . . 75.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.656 2.238 . . . . 74.25 112.337 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.34 148.91 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.099999999999994 111.098 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.44 102.81 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 73.549999999999997 110.926 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -52.3 -36.55 53.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 111.186 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.27 179.68 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 44.109999999999999 110.872 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.56 69.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.542 0.687 . . . . 75.120000000000005 110.917 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 161.51 45.62 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 74.329999999999998 112.373 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.37 -49.53 3.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 54.310000000000002 112.465 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -65.42 143.84 57.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 75.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -86.66 136.57 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 111.108 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -83.19 131.74 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 63.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.23 156.15 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.329999999999998 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.45 51.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 110.897 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.43 -32.9 36.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 71.209999999999994 112.506 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.26 165.55 11.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 74.209999999999994 110.91 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -48.05 -34.32 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 110.84 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.15 138.22 14.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 64.409999999999997 112.478 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -52.05 128.88 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 73.25 110.905 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.0 175.55 21.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 73.219999999999999 112.461 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.3 p -114.04 129.29 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 74.030000000000001 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 110.894 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.61 0.719 . . . . 74.209999999999994 110.836 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.625 2.216 . . . . 74.549999999999997 112.311 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.04 160.54 27.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 72.25 110.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -33.05 17.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.698 2.265 . . . . 74.230000000000004 112.357 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.38 149.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 63.530000000000001 111.148 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -71.72 99.75 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 75.450000000000003 110.888 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -110.86 -39.58 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.516 . . . . 75.409999999999997 111.155 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 89.6 m -74.33 -175.22 2.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.219999999999999 110.851 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -111.25 157.24 39.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 73.239999999999995 110.879 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 160.81 48.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.258 . . . . 74.310000000000002 112.341 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 -48.99 3.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 70.239999999999995 112.494 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.65 149.06 49.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 72.400000000000006 110.902 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 111.195 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -79.1 129.09 34.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 74.450000000000003 110.888 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.13 161.19 22.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.19 47.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.876 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.65 -88.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 72.329999999999998 112.526 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.55 165.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.792 0.329 . . . . 75.319999999999993 110.961 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -49.06 -34.37 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.846 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.65 17.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 72.549999999999997 112.471 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -51.89 130.09 28.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.93 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.15 166.08 24.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 63.219999999999999 112.505 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.4 p -119.9 113.05 19.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 53.109999999999999 110.873 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 61.020000000000003 110.846 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.661 0.744 . . . . 63.240000000000002 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.25 16.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.719 2.279 . . . . 73.150000000000006 112.361 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.97 160.57 1.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.561 0.696 . . . . 72.540000000000006 110.88 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.84 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 62.039999999999999 112.36 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.37 143.41 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -120.34 163.69 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 110.922 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -51.79 -35.84 45.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 62.109999999999999 111.173 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.2 m -52.94 169.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 71.239999999999995 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -93.64 159.22 35.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 70.120000000000005 110.838 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.99 10.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 75.420000000000002 112.32 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -50.48 4.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 54.020000000000003 112.47 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -64.64 149.84 48.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.420000000000002 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -82.64 142.42 31.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.519999999999996 111.121 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -82.43 132.85 35.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 71.439999999999998 110.888 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.76 143.16 45.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.299999999999997 110.873 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -109.44 37.2 2.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.140000000000001 110.9 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 51.329999999999998 112.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -51.94 164.47 0.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 73.129999999999995 110.933 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.97 -35.93 47.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 71.030000000000001 110.863 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 138.54 14.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 73.099999999999994 112.53 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -52.34 129.27 27.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.915 0.388 . . . . 75.040000000000006 110.886 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.92 175.04 21.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 72.120000000000005 112.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.9 p -104.93 136.97 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 72.530000000000001 110.888 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 71.510000000000005 110.863 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.616 0.722 . . . . 64.109999999999999 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.88 17.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 70.239999999999995 112.346 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -173.14 65.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 70.209999999999994 110.844 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.675 2.25 . . . . 72.349999999999994 112.344 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.3 m -101.77 107.39 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.530000000000001 111.144 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -130.84 164.04 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 110.886 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.3 p -51.69 -34.54 38.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.077 -0.51 . . . . 74.340000000000003 111.107 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.44 -171.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 75.239999999999995 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -111.02 160.97 26.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.616 0.722 . . . . 75.219999999999999 110.847 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 64.519999999999996 112.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.78 -45.88 3.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 72.319999999999993 112.479 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.13 152.2 41.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.396 . . . . 73.120000000000005 110.901 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 t -81.39 144.82 31.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 111.15 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.4 t -79.41 140.43 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 70.409999999999997 110.906 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.16 136.63 53.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.230000000000004 110.933 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.25 35.64 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 110.892 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.62 -64.23 3.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 61.25 112.466 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.92 165.08 25.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 110.917 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -49.75 -34.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.87 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.91 140.72 16.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 71.200000000000003 112.511 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -51.54 133.05 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.399 . . . . 73.420000000000002 110.901 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.66 175.61 20.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 51.210000000000001 112.508 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -98.38 129.81 45.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 65.310000000000002 110.881 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 64.219999999999999 110.865 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.665 0.745 . . . . 74.219999999999999 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 79.12 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 75.019999999999996 112.353 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -116.77 73.41 6.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.71 . . . . 63.25 110.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.15 17.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.25 . . . . 71.430000000000007 112.361 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.95 145.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -72.4 103.91 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 75.349999999999994 110.941 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -118.34 -47.18 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 73.340000000000003 111.096 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 m -113.21 171.17 7.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.63 160.57 50.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 75.299999999999997 110.902 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.21 28.35 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.673 2.249 . . . . 74.019999999999996 112.38 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.48 -49.55 3.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.72 . . . . 75.019999999999996 112.493 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.34 143.58 56.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.927 0.394 . . . . 71.310000000000002 110.9 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -87.54 136.64 32.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 111.172 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.66 132.51 35.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.25 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -126.52 147.33 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.919 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -105.11 35.8 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.08 -80.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 71.120000000000005 112.511 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -51.94 164.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 70.239999999999995 110.939 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -51.09 -35.17 33.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 63.5 110.88 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.58 139.5 14.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 62.409999999999997 112.488 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -51.92 130.06 28.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 71.310000000000002 110.923 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.18 175.39 26.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 60.520000000000003 112.499 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -114.47 133.15 55.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 71.019999999999996 110.929 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 72.040000000000006 110.847 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.607 0.717 . . . . 74.310000000000002 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -34.26 15.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.704 2.27 . . . . 72.409999999999997 112.35 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.76 160.71 1.02 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.430000000000007 110.902 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 77.99 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.747 2.298 . . . . 70.120000000000005 112.323 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.64 150.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 111.121 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.15 98.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 110.94 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -51.66 126.12 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 71.409999999999997 111.113 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 m -89.68 -169.54 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.340000000000003 110.853 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -60.76 160.6 18.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.633 0.73 . . . . 72.510000000000005 110.861 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.84 55.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 73.400000000000006 112.338 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 -47.64 3.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 72.409999999999997 112.471 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.32 151.95 42.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.352 . . . . 71.439999999999998 110.919 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -108.54 145.16 35.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 111.132 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.3 t -78.81 114.14 17.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 44.32 110.906 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.96 161.18 14.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 62.329999999999998 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -123.6 143.38 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.109999999999999 110.867 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.95 -32.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 73.519999999999996 112.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 166.29 10.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.355 . . . . 75.5 110.877 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -46.5 -34.64 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.099999999999994 110.845 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.26 14.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 75.25 112.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -51.67 142.14 15.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 71.420000000000002 110.916 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.04 169.48 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 35.140000000000001 112.48 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 p -125.12 112.94 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.876 0.369 . . . . 72.409999999999997 110.899 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.883 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.593 0.711 . . . . 72.439999999999998 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.56 18.15 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.223 . . . . 74.430000000000007 112.378 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.19 158.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.617 0.722 . . . . 74.530000000000001 110.861 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 165.98 29.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.682 2.255 . . . . 63.020000000000003 112.361 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p -55.25 122.95 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.16 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -119.26 143.79 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 75.120000000000005 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -53.44 123.25 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 73.319999999999993 111.145 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.23 175.77 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.926 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -107.22 157.65 34.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.657 0.741 . . . . 74.540000000000006 110.812 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 158.26 57.58 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.698 2.265 . . . . 64.439999999999998 112.321 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -48.09 3.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 40.119999999999997 112.549 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.49 127.27 30.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 75.25 110.888 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -83.62 145.05 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 111.167 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.2 t -78.96 114.12 17.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.310000000000002 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 p -121.66 170.34 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 64.239999999999995 110.919 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.22 33.63 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.863 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.31 -70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 71.140000000000001 112.472 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.6 mt -58.72 165.03 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 74.239999999999995 110.918 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -50.15 -34.74 23.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.833 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.89 138.49 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.319999999999993 112.434 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -51.86 129.78 27.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 74.200000000000003 110.908 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.07 175.58 29.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 74.400000000000006 112.503 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.8 p -106.1 127.93 53.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.239999999999995 110.845 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.83 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.652 0.739 . . . . 73.209999999999994 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -40.57 5.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 75.329999999999998 112.335 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.11 160.56 2.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.595 0.712 . . . . 65.540000000000006 110.854 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -44.05 2.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.687 2.258 . . . . 74.310000000000002 112.389 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.31 133.23 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 111.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.24 125.9 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 72.519999999999996 110.935 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -84.16 -36.04 23.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.169 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.45 179.71 4.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.875 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -66.76 160.63 67.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 71.450000000000003 110.888 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 157.07 61.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 73.239999999999995 112.305 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.57 3.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 62.0 112.49 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -64.62 140.34 58.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 74.319999999999993 110.922 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -87.73 144.55 26.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 75.530000000000001 111.09 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.99 127.53 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 65.230000000000004 110.888 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -120.8 141.98 50.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -99.56 35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.5 -81.43 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.762 . . . . 61.140000000000001 112.47 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -51.91 164.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.793 0.33 . . . . 74.030000000000001 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -51.23 -35.43 36.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 72.409999999999997 110.852 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.05 140.42 15.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 63.100000000000001 112.508 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -51.83 126.24 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 71.430000000000007 110.985 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.2 175.52 20.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 73.140000000000001 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.36 115.34 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 63.229999999999997 110.904 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.099999999999994 110.836 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.629 0.728 . . . . 74.310000000000002 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 91.67 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.664 2.243 . . . . 72.540000000000006 112.364 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -133.47 160.58 68.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.591 0.71 . . . . 62.210000000000001 110.917 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -44.94 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.728 2.285 . . . . 72.109999999999999 112.337 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.05 134.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.122 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -90.64 142.51 27.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.489 . . . . 73.430000000000007 110.932 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -110.02 -64.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 111.152 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 m -81.74 179.2 7.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 75.239999999999995 110.839 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -77.5 160.6 74.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 74.450000000000003 110.861 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.94 51.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 74.439999999999998 112.359 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -49.59 3.91 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 73.5 112.455 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -65.12 149.57 49.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 74.299999999999997 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -90.39 137.05 32.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 75.450000000000003 111.165 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.1 127.92 35.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.9 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -123.87 149.98 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.62 38.49 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.019999999999996 110.894 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.33 -64.59 2.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.732 -0.746 . . . . 61.210000000000001 112.49 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.97 164.73 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.899 0.381 . . . . 74.409999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -51.18 -35.38 35.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 110.869 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.53 138.43 14.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 72.230000000000004 112.492 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.0 127.79 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 74.510000000000005 110.931 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.99 175.4 27.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.756 -0.735 . . . . 75.540000000000006 112.508 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 p -112.63 127.62 56.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 74.219999999999999 110.879 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.400000000000006 110.887 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 73.439999999999998 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 145.16 56.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.255 . . . . 71.109999999999999 112.323 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.27 160.08 1.18 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 74.310000000000002 110.85 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -43.33 2.7 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.678 2.252 . . . . 65.340000000000003 112.334 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.06 149.18 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.095 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -72.06 114.96 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 64.209999999999994 110.936 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -70.24 177.71 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 75.239999999999995 111.138 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.0 m -70.94 -175.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 61.310000000000002 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -61.4 160.6 23.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.573 0.701 . . . . 75.530000000000001 110.904 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 169.58 18.54 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.725 2.283 . . . . 72.530000000000001 112.373 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -50.35 4.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 61.100000000000001 112.512 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.96 151.59 45.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 74.409999999999997 110.946 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 t -82.87 143.87 30.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t -94.04 148.12 22.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.851 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.2 p -130.49 141.78 50.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.430000000000007 110.91 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -111.1 37.74 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 -77.75 0.54 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.725 -0.75 . . . . 62.219999999999999 112.491 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -51.95 164.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 74.120000000000005 110.893 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -51.97 -35.92 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 74.510000000000005 110.873 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.95 138.7 14.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 71.030000000000001 112.509 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -52.91 132.36 37.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 73.340000000000003 110.913 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.82 170.19 25.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 72.150000000000006 112.499 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.6 p -99.19 140.52 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 71.540000000000006 110.889 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 65.230000000000004 110.822 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.624 0.726 . . . . 71.319999999999993 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -33.23 17.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.662 2.241 . . . . 72.200000000000003 112.343 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.97 160.59 1.12 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 75.450000000000003 110.919 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -33.12 17.26 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.725 2.283 . . . . 71.319999999999993 112.327 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -55.36 121.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 65.140000000000001 111.095 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.5 123.68 49.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 110.912 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -100.96 -37.99 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.349999999999994 111.144 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -120.8 175.11 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.340000000000003 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -63.35 159.1 52.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.741 . . . . 74.329999999999998 110.85 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 167.9 23.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.654 2.236 . . . . 72.239999999999995 112.346 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.51 -51.31 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 60.020000000000003 112.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.67 144.62 57.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 64.439999999999998 110.89 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -82.29 144.56 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 71.230000000000004 111.166 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.55 117.92 27.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 73.109999999999999 110.918 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.1 p -98.92 139.35 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.549999999999997 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -100.31 35.74 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.41 -82.65 0.16 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 73.140000000000001 112.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.4 mt -51.88 164.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 64.230000000000004 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -51.47 -35.5 40.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.099999999999994 110.864 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.63 140.79 15.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 74.420000000000002 112.469 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -52.0 125.0 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 75.239999999999995 110.951 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.3 175.47 20.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 71.319999999999993 112.496 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -106.57 132.73 52.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 63.530000000000001 110.85 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 71.519999999999996 110.883 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.616 0.722 . . . . 71.540000000000006 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 82.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.25 . . . . 75.400000000000006 112.355 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.0 160.52 30.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 73.519999999999996 110.87 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -48.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.723 2.282 . . . . 72.209999999999994 112.335 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.49 150.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.219999999999999 111.133 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.0 107.92 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 110.912 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -96.81 -37.26 10.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 63.130000000000003 111.144 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.3 m -106.73 179.5 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 74.409999999999997 110.879 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -97.83 160.54 28.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 61.140000000000001 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 163.38 38.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 71.230000000000004 112.388 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -49.45 3.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 71.310000000000002 112.492 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -65.55 136.1 55.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 71.519999999999996 110.919 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -83.01 139.84 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 63.530000000000001 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -79.43 114.21 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 75.510000000000005 110.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.32 143.84 27.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 110.885 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -103.98 38.85 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.859 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.47 -82.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.329999999999998 112.486 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -51.88 164.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 65.209999999999994 110.949 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -51.57 -35.62 41.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.827 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.2 138.64 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 71.409999999999997 112.479 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -51.96 123.32 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 73.439999999999998 110.924 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.22 175.51 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 75.400000000000006 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 p -114.69 121.02 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 74.239999999999995 110.858 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.912 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.627 0.727 . . . . 71.109999999999999 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 95.89 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.701 2.268 . . . . 72.129999999999995 112.328 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.54 160.04 1.11 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.568 0.699 . . . . 72.530000000000001 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -48.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.246 . . . . 72.450000000000003 112.317 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -101.51 150.14 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.549999999999997 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -97.62 160.47 14.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.019999999999996 110.918 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -118.18 -66.11 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 64.109999999999999 111.138 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 m -60.85 -179.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.140000000000001 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -74.09 160.56 81.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 73.239999999999995 110.85 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 159.31 53.9 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.702 2.268 . . . . 74.010000000000005 112.304 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.02 -51.27 4.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.432 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.59 128.76 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 61.439999999999998 110.899 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -81.51 144.7 31.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 111.12 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -83.89 119.02 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 110.918 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 p -106.66 153.75 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.854 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 35.74 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 110.831 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.1 -74.26 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 72.140000000000001 112.47 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.09 164.59 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 75.430000000000007 110.932 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -51.54 -35.65 41.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.874 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.25 138.51 14.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 70.129999999999995 112.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -52.01 130.57 30.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 74.439999999999998 110.899 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.08 175.49 30.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 65.340000000000003 112.49 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -106.14 134.42 49.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 73.310000000000002 110.933 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 110.887 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.612 0.72 . . . . 63.219999999999999 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.01 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.634 2.222 . . . . 74.430000000000007 112.373 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.54 158.53 1.46 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.576 0.703 . . . . 74.319999999999993 110.87 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 -34.6 13.84 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.65 2.233 . . . . 64.239999999999995 112.339 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.2 120.43 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.409999999999997 111.102 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.76 163.12 14.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 75.549999999999997 110.974 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -123.88 -57.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.019999999999996 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.5 174.78 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.120000000000005 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.17 160.53 78.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.581 0.705 . . . . 72.409999999999997 110.872 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 170.17 17.16 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.669 2.246 . . . . 74.340000000000003 112.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.56 -51.51 4.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.738 . . . . 71.239999999999995 112.505 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -64.83 147.68 52.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 70.540000000000006 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 p -83.66 143.34 30.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 111.137 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t -87.24 149.7 24.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -135.48 138.74 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.230000000000004 110.896 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 ttp85 -105.09 37.79 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.889 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.98 -78.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 71.239999999999995 112.481 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.5 mt -52.56 164.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 62.149999999999999 110.912 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -35.72 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.420000000000002 110.868 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.59 140.65 15.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.481 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -52.02 123.91 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 75.540000000000006 110.926 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.62 171.77 21.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.713 -0.756 . . . . 62.240000000000002 112.48 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -105.71 129.59 53.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 73.510000000000005 110.861 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 74.0 110.89 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.686 0.755 . . . . 74.109999999999999 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 84.68 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 74.430000000000007 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -114.31 73.43 2.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.732 . . . . 73.209999999999994 110.879 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -33.15 17.28 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 73.239999999999995 112.352 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -67.6 146.59 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.319999999999993 111.117 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.14 98.13 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.925 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.33 -51.19 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 64.129999999999995 111.162 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.57 171.44 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 51.530000000000001 110.837 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -91.06 159.01 40.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.624 0.726 . . . . 63.43 110.854 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.52 16.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.652 2.235 . . . . 74.209999999999994 112.326 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.46 -49.5 3.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 71.219999999999999 112.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.66 144.71 57.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.439999999999998 110.892 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -84.51 144.71 28.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.420000000000002 111.146 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.5 t -79.33 140.98 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 72.5 110.834 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 p -119.45 147.45 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 72.209999999999994 110.88 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -102.03 133.75 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.886 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.89 -89.44 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 71.019999999999996 112.477 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.02 165.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.420000000000002 110.896 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -49.12 -34.26 13.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.66 149.97 17.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.696 -0.764 . . . . 75.230000000000004 112.491 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -51.55 132.69 30.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 75.439999999999998 110.911 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.4 165.63 12.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.69 -0.767 . . . . 72.439999999999998 112.478 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.6 p -120.06 113.02 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.25 110.921 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 110.879 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.643 0.735 . . . . 72.420000000000002 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -46.43 1.26 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.385 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -145.44 68.44 13.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 74.409999999999997 110.865 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 176.5 6.68 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.655 2.236 . . . . 74.549999999999997 112.388 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.66 147.06 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 73.519999999999996 111.161 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.35 98.16 8.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.948 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -135.77 -41.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 75.430000000000007 111.106 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.04 -179.86 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 74.150000000000006 110.858 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -95.29 159.3 33.14 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.565 0.697 . . . . 73.319999999999993 110.878 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 163.07 39.66 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.688 2.259 . . . . 75.209999999999994 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -45.8 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 71.150000000000006 112.48 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.18 144.54 57.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 74.430000000000007 110.923 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -94.2 144.94 25.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 62.030000000000001 111.178 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 t -79.17 133.2 36.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.140000000000001 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.99 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.409999999999997 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttp85 -102.6 41.81 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 75.209999999999994 110.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.57 -78.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 71.25 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.77 165.14 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 74.340000000000003 110.883 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -49.8 -34.55 19.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 61.350000000000001 110.837 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.43 141.51 15.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 62.229999999999997 112.483 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.67 126.36 17.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.944 0.402 . . . . 75.409999999999997 110.88 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.06 167.56 18.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 65.129999999999995 112.463 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 p -121.52 119.72 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 64.109999999999999 110.875 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.549999999999997 110.883 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.688 0.756 . . . . 72.140000000000001 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 133.93 26.93 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 75.319999999999993 112.357 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.61 160.14 48.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 73.409999999999997 110.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -39.9 5.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 73.420000000000002 112.33 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.82 112.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.540000000000006 111.101 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -84.93 100.53 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 73.519999999999996 110.922 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -125.86 -42.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 75.329999999999998 111.154 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.57 178.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.867 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.85 157.61 59.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.578 0.704 . . . . 74.310000000000002 110.877 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 162.57 41.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.33 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.59 3.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 65.329999999999998 112.483 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -64.67 143.53 57.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.878 0.371 . . . . 74.329999999999998 110.907 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 t -83.79 139.18 32.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.12 136.67 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.400000000000006 110.855 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.06 151.33 50.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.030000000000001 110.892 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 37.06 3.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 110.862 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.84 -82.56 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 63.25 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 164.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.375 . . . . 73.349999999999994 110.9 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -50.45 -34.96 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.230000000000004 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.14 142.14 15.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.667 -0.778 . . . . 72.430000000000007 112.458 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.55 133.9 52.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 74.329999999999998 110.954 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.91 175.44 29.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 73.099999999999994 112.464 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.0 p -114.98 122.02 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 70.519999999999996 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 110.86 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.629 0.728 . . . . 74.329999999999998 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -33.58 16.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.64 2.226 . . . . 74.400000000000006 112.325 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.02 160.52 78.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 61.509999999999998 110.839 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -42.48 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.236 . . . . 75.319999999999993 112.312 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.41 145.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 70.439999999999998 111.095 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -129.73 104.75 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 72.329999999999998 110.923 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -111.33 -35.78 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 72.109999999999999 111.128 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.36 168.56 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 63.520000000000003 110.935 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -83.85 159.15 61.01 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.71 . . . . 74.439999999999998 110.892 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 169.77 18.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 74.340000000000003 112.323 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.56 -50.29 4.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 62.520000000000003 112.53 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -64.66 152.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 71.450000000000003 110.92 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 t -88.59 144.63 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 111.11 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.73 132.77 34.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 62.100000000000001 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.9 p -113.29 143.85 43.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.010000000000005 110.887 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -110.34 51.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.825 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.08 -78.74 1.15 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 64.310000000000002 112.484 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -51.62 165.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 74.040000000000006 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -49.07 -34.27 13.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 75.329999999999998 110.85 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.51 -172.25 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 60.240000000000002 112.485 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -89.69 127.7 35.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 72.439999999999998 110.902 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.24 175.35 19.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 72.299999999999997 112.458 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 p -119.14 124.71 47.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.367 . . . . 63.140000000000001 110.852 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.239999999999995 110.838 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.666 0.746 . . . . 65.5 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -37.53 9.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.252 . . . . 72.439999999999998 112.376 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.21 68.16 0.2 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 64.209999999999994 110.834 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 73.310000000000002 112.364 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.26 150.22 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.530000000000001 111.142 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 98.1 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.94 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.53 -52.89 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 63.310000000000002 111.105 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 m -67.49 169.74 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 62.340000000000003 110.878 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 155.86 67.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 73.340000000000003 110.909 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 155.95 64.46 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.722 2.282 . . . . 73.140000000000001 112.317 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.54 -48.89 3.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 71.420000000000002 112.511 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.45 129.93 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 110.899 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -85.82 144.78 27.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.340000000000003 111.148 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -79.25 131.9 36.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 64.349999999999994 110.907 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.11 153.78 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 110.862 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -107.92 40.58 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.099999999999994 110.836 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.28 -81.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 72.329999999999998 112.471 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.86 164.84 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 75.219999999999999 110.86 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -50.73 -35.12 29.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 73.299999999999997 110.894 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.39 144.69 15.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 63.509999999999998 112.483 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -51.86 127.39 20.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 70.129999999999995 110.938 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.93 175.54 21.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 71.219999999999999 112.491 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.83 123.32 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 70.209999999999994 110.893 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.540000000000006 110.865 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.609 0.719 . . . . 62.229999999999997 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.259 . . . . 65.340000000000003 112.356 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -117.65 68.68 6.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 71.120000000000005 110.857 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 64.129999999999995 112.351 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.91 149.89 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 111.092 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.11 98.4 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 110.933 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -130.55 -49.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 73.150000000000006 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.21 -174.36 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 157.61 50.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 73.239999999999995 110.854 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.89 26.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 71.030000000000001 112.319 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 -49.85 4.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 61.009999999999998 112.49 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -64.84 144.95 56.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.914 0.388 . . . . 74.510000000000005 110.861 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -85.19 144.57 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.230000000000004 111.151 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -79.38 140.42 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.861 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.17 138.65 51.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.891 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -109.9 54.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.904 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.76 1.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 52.420000000000002 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.6 165.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 74.430000000000007 110.937 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -49.41 -34.47 16.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.828 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.17 -174.77 31.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 73.209999999999994 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.7 129.41 36.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.925 0.393 . . . . 75.329999999999998 110.909 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.22 168.7 20.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 72.040000000000006 112.525 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -117.86 115.59 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 72.150000000000006 110.905 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 54.219999999999999 110.871 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.651 0.738 . . . . 54.140000000000001 110.859 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -33.43 16.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.727 2.285 . . . . 65.340000000000003 112.314 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.99 160.49 1.15 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.644 0.735 . . . . 75.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.656 2.238 . . . . 74.25 112.337 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.34 148.91 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.099999999999994 111.098 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.44 102.81 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 73.549999999999997 110.926 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -52.3 -36.55 53.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.329999999999998 111.186 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.27 179.68 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 44.109999999999999 110.872 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.56 69.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.542 0.687 . . . . 75.120000000000005 110.917 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 161.51 45.62 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 74.329999999999998 112.373 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.37 -49.53 3.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 54.310000000000002 112.465 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -65.42 143.84 57.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 75.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -86.66 136.57 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 111.108 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -83.19 131.74 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 63.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.23 156.15 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.329999999999998 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.45 51.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 110.897 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.43 -32.9 36.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 71.209999999999994 112.506 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.26 165.55 11.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 74.209999999999994 110.91 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -48.05 -34.32 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 110.84 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.15 138.22 14.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 64.409999999999997 112.478 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -52.05 128.88 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 73.25 110.905 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.0 175.55 21.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 73.219999999999999 112.461 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.3 p -114.04 129.29 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 74.030000000000001 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 110.894 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.61 0.719 . . . . 74.209999999999994 110.836 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.625 2.216 . . . . 74.549999999999997 112.311 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.04 160.54 27.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 72.25 110.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -33.05 17.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.698 2.265 . . . . 74.230000000000004 112.357 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.38 149.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 63.530000000000001 111.148 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -71.72 99.75 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 75.450000000000003 110.888 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -110.86 -39.58 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.516 . . . . 75.409999999999997 111.155 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 89.6 m -74.33 -175.22 2.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.219999999999999 110.851 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -111.25 157.24 39.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 73.239999999999995 110.879 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 160.81 48.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.258 . . . . 74.310000000000002 112.341 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 -48.99 3.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 70.239999999999995 112.494 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.65 149.06 49.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 72.400000000000006 110.902 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 111.195 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -79.1 129.09 34.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 74.450000000000003 110.888 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.13 161.19 22.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.19 47.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.876 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.65 -88.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 72.329999999999998 112.526 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.55 165.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.792 0.329 . . . . 75.319999999999993 110.961 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -49.06 -34.37 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.846 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.65 17.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 72.549999999999997 112.471 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -51.89 130.09 28.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.93 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.15 166.08 24.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 63.219999999999999 112.505 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.4 p -119.9 113.05 19.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 53.109999999999999 110.873 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 61.020000000000003 110.846 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.661 0.744 . . . . 63.240000000000002 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.25 16.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.719 2.279 . . . . 73.150000000000006 112.361 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.97 160.57 1.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.561 0.696 . . . . 72.540000000000006 110.88 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.84 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 62.039999999999999 112.36 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.37 143.41 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -120.34 163.69 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 110.922 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -51.79 -35.84 45.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 62.109999999999999 111.173 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.2 m -52.94 169.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 71.239999999999995 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -93.64 159.22 35.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 70.120000000000005 110.838 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.99 10.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 75.420000000000002 112.32 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -50.48 4.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 54.020000000000003 112.47 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -64.64 149.84 48.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.420000000000002 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -82.64 142.42 31.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.519999999999996 111.121 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -82.43 132.85 35.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 71.439999999999998 110.888 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.76 143.16 45.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.299999999999997 110.873 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -109.44 37.2 2.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.140000000000001 110.9 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 51.329999999999998 112.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -51.94 164.47 0.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 73.129999999999995 110.933 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.97 -35.93 47.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 71.030000000000001 110.863 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 138.54 14.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 73.099999999999994 112.53 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -52.34 129.27 27.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.915 0.388 . . . . 75.040000000000006 110.886 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.92 175.04 21.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 72.120000000000005 112.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.9 p -104.93 136.97 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 72.530000000000001 110.888 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 71.510000000000005 110.863 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.616 0.722 . . . . 64.109999999999999 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.88 17.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 70.239999999999995 112.346 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -173.14 65.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 70.209999999999994 110.844 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.675 2.25 . . . . 72.349999999999994 112.344 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.3 m -101.77 107.39 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.530000000000001 111.144 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -130.84 164.04 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 110.886 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.3 p -51.69 -34.54 38.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.077 -0.51 . . . . 74.340000000000003 111.107 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.44 -171.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 75.239999999999995 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -111.02 160.97 26.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.616 0.722 . . . . 75.219999999999999 110.847 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 64.519999999999996 112.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.78 -45.88 3.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 72.319999999999993 112.479 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.13 152.2 41.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.396 . . . . 73.120000000000005 110.901 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 t -81.39 144.82 31.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 111.15 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.4 t -79.41 140.43 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 70.409999999999997 110.906 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.16 136.63 53.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.230000000000004 110.933 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.25 35.64 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 110.892 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.62 -64.23 3.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 61.25 112.466 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.92 165.08 25.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 110.917 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -49.75 -34.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.87 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.91 140.72 16.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 71.200000000000003 112.511 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -51.54 133.05 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.399 . . . . 73.420000000000002 110.901 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.66 175.61 20.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 51.210000000000001 112.508 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -98.38 129.81 45.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 65.310000000000002 110.881 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 64.219999999999999 110.865 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.665 0.745 . . . . 74.219999999999999 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 79.12 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 75.019999999999996 112.353 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -116.77 73.41 6.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.71 . . . . 63.25 110.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.15 17.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.25 . . . . 71.430000000000007 112.361 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.95 145.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -72.4 103.91 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 75.349999999999994 110.941 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -118.34 -47.18 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 73.340000000000003 111.096 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 m -113.21 171.17 7.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.63 160.57 50.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 75.299999999999997 110.902 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.21 28.35 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.673 2.249 . . . . 74.019999999999996 112.38 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.48 -49.55 3.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.72 . . . . 75.019999999999996 112.493 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.34 143.58 56.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.927 0.394 . . . . 71.310000000000002 110.9 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -87.54 136.64 32.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 111.172 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.66 132.51 35.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.25 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -126.52 147.33 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.919 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -105.11 35.8 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.08 -80.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 71.120000000000005 112.511 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -51.94 164.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 70.239999999999995 110.939 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -51.09 -35.17 33.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 63.5 110.88 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.58 139.5 14.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 62.409999999999997 112.488 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -51.92 130.06 28.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 71.310000000000002 110.923 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.18 175.39 26.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 60.520000000000003 112.499 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -114.47 133.15 55.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 71.019999999999996 110.929 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 72.040000000000006 110.847 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.607 0.717 . . . . 74.310000000000002 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -34.26 15.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.704 2.27 . . . . 72.409999999999997 112.35 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.76 160.71 1.02 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.430000000000007 110.902 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 77.99 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.747 2.298 . . . . 70.120000000000005 112.323 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.64 150.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 111.121 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.15 98.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 110.94 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -51.66 126.12 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 71.409999999999997 111.113 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 m -89.68 -169.54 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.340000000000003 110.853 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -60.76 160.6 18.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.633 0.73 . . . . 72.510000000000005 110.861 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.84 55.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 73.400000000000006 112.338 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 -47.64 3.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 72.409999999999997 112.471 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.32 151.95 42.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.352 . . . . 71.439999999999998 110.919 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -108.54 145.16 35.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 111.132 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.3 t -78.81 114.14 17.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 44.32 110.906 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.96 161.18 14.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 62.329999999999998 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -123.6 143.38 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.109999999999999 110.867 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.95 -32.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 73.519999999999996 112.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 166.29 10.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.355 . . . . 75.5 110.877 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -46.5 -34.64 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.099999999999994 110.845 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.26 14.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 75.25 112.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -51.67 142.14 15.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 71.420000000000002 110.916 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.04 169.48 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 35.140000000000001 112.48 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 p -125.12 112.94 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.876 0.369 . . . . 72.409999999999997 110.899 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.883 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.593 0.711 . . . . 72.439999999999998 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.56 18.15 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.223 . . . . 74.430000000000007 112.378 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.19 158.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.617 0.722 . . . . 74.530000000000001 110.861 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 165.98 29.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.682 2.255 . . . . 63.020000000000003 112.361 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p -55.25 122.95 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.16 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -119.26 143.79 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 75.120000000000005 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -53.44 123.25 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 73.319999999999993 111.145 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.23 175.77 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.926 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -107.22 157.65 34.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.657 0.741 . . . . 74.540000000000006 110.812 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 158.26 57.58 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.698 2.265 . . . . 64.439999999999998 112.321 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -48.09 3.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 40.119999999999997 112.549 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.49 127.27 30.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 75.25 110.888 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -83.62 145.05 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 111.167 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.2 t -78.96 114.12 17.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.310000000000002 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 p -121.66 170.34 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 64.239999999999995 110.919 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.22 33.63 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.863 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.31 -70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 71.140000000000001 112.472 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.6 mt -58.72 165.03 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 74.239999999999995 110.918 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -50.15 -34.74 23.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.833 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.89 138.49 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.319999999999993 112.434 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -51.86 129.78 27.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 74.200000000000003 110.908 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.07 175.58 29.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 74.400000000000006 112.503 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.8 p -106.1 127.93 53.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.239999999999995 110.845 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.83 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.652 0.739 . . . . 31.03 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -40.57 5.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 53.15 112.335 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.11 160.56 2.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.595 0.712 . . . . 65.54 110.854 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -44.05 2.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.687 2.258 . . . . 64.25 112.389 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.31 133.23 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 44.35 111.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.24 125.9 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 71.03 110.935 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -84.16 -36.04 23.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 63.34 111.169 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.45 179.71 4.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.1 110.875 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -66.76 160.63 67.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 71.45 110.888 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 157.07 61.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 61.42 112.305 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.57 3.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 62.0 112.49 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -64.62 140.34 58.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 60.54 110.922 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -87.73 144.55 26.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 75.53 111.09 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.99 127.53 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.888 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -120.8 141.98 50.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 44.51 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -99.56 35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.42 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.5 -81.43 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.762 . . . . 41.55 112.47 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -51.91 164.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.793 0.33 . . . . 74.03 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -51.23 -35.43 36.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 72.41 110.852 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.05 140.42 15.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 63.1 112.508 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -51.83 126.24 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 71.43 110.985 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.2 175.52 20.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 73.14 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.36 115.34 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 63.23 110.904 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.1 110.836 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.629 0.728 . . . . 72.43 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 91.67 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.664 2.243 . . . . 72.54 112.364 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -133.47 160.58 68.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.591 0.71 . . . . 62.21 110.917 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -44.94 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.728 2.285 . . . . 72.11 112.337 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.05 134.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 62.15 111.122 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -90.64 142.51 27.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.489 . . . . 73.43 110.932 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -110.02 -64.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 51.24 111.152 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 m -81.74 179.2 7.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.11 110.839 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -77.5 160.6 74.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 71.55 110.861 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.94 51.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 61.24 112.359 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -49.59 3.91 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 73.5 112.455 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -65.12 149.57 49.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 74.3 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -90.39 137.05 32.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 65.11 111.165 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.1 127.92 35.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.9 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -123.87 149.98 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.62 38.49 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.894 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.33 -64.59 2.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.732 -0.746 . . . . 53.24 112.49 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.97 164.73 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.899 0.381 . . . . 74.34 110.898 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -51.18 -35.38 35.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.869 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.53 138.43 14.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 64.14 112.492 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.0 127.79 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 73.33 110.931 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.99 175.4 27.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.756 -0.735 . . . . 75.44 112.508 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 p -112.63 127.62 56.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 65.33 110.879 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.887 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 63.41 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 145.16 56.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.255 . . . . 41.13 112.323 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.27 160.08 1.18 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 74.31 110.85 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -43.33 2.7 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.678 2.252 . . . . 62.4 112.334 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.06 149.18 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.42 111.095 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -72.06 114.96 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 61.25 110.936 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -70.24 177.71 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 53.45 111.138 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.0 m -70.94 -175.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 45.21 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -61.4 160.6 23.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.573 0.701 . . . . 75.53 110.904 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 169.58 18.54 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.725 2.283 . . . . 72.53 112.373 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -50.35 4.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 43.15 112.512 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.96 151.59 45.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 74.41 110.946 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 t -82.87 143.87 30.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t -94.04 148.12 22.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 41.01 110.851 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.2 p -130.49 141.78 50.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.91 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -111.1 37.74 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.31 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 -77.75 0.54 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.725 -0.75 . . . . 45.12 112.491 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -51.95 164.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 73.24 110.893 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -51.97 -35.92 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 74.51 110.873 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.95 138.7 14.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 52.13 112.509 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -52.91 132.36 37.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 72.4 110.913 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.82 170.19 25.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 41.14 112.499 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.6 p -99.19 140.52 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 52.21 110.889 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 65.23 110.822 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.624 0.726 . . . . 64.11 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -33.23 17.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.662 2.241 . . . . 72.11 112.343 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 5' ' ' VAL . 6.6 m-20 -51.97 160.59 1.12 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 75.45 110.919 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -33.12 17.26 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.725 2.283 . . . . 71.32 112.327 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 3' ' ' ASP . 17.5 m -55.36 121.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 63.12 111.095 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.5 123.68 49.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.912 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -100.96 -37.99 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 51.21 111.144 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -120.8 175.11 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.34 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -63.35 159.1 52.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.741 . . . . 74.33 110.85 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 167.9 23.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.654 2.236 . . . . 71.22 112.346 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.51 -51.31 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 60.02 112.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.67 144.62 57.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 53.04 110.89 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -82.29 144.56 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 71.23 111.166 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.55 117.92 27.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.918 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.1 p -98.92 139.35 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -100.31 35.74 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.41 -82.65 0.16 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 73.14 112.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.4 mt -51.88 164.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 64.23 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -51.47 -35.5 40.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.864 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.63 140.79 15.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 51.33 112.469 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -52.0 125.0 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 75.24 110.951 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.3 175.47 20.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 44.43 112.496 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -106.57 132.73 52.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 63.43 110.85 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.883 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.616 0.722 . . . . 71.54 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 82.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.25 . . . . 75.4 112.355 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.0 160.52 30.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 61.54 110.87 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -48.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.723 2.282 . . . . 62.23 112.335 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.49 150.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.34 111.133 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.0 107.92 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 71.1 110.912 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -96.81 -37.26 10.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 62.41 111.144 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.3 m -106.73 179.5 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.879 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -97.83 160.54 28.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 60.25 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 163.38 38.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 64.11 112.388 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -49.45 3.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 71.31 112.492 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -65.55 136.1 55.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 64.44 110.919 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -83.01 139.84 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -79.43 114.21 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 75.51 110.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.32 143.84 27.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.885 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -103.98 38.85 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.859 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.47 -82.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.486 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.4 mp -51.88 164.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.42 110.949 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -51.57 -35.62 41.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.827 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.2 138.64 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.479 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -51.96 123.32 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 73.44 110.924 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.22 175.51 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 75.4 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 p -114.69 121.02 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 74.24 110.858 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 52.24 110.912 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.627 0.727 . . . . 50.35 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 95.89 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.701 2.268 . . . . 72.13 112.328 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.54 160.04 1.11 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.568 0.699 . . . . 72.05 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -48.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.246 . . . . 71.13 112.317 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -101.51 150.14 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.55 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -97.62 160.47 14.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.918 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -118.18 -66.11 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 64.11 111.138 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 m -60.85 -179.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.14 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -74.09 160.56 81.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 73.24 110.85 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 159.31 53.9 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.702 2.268 . . . . 64.04 112.304 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.02 -51.27 4.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 52.03 112.432 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.59 128.76 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 61.44 110.899 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -81.51 144.7 31.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.32 111.12 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -83.89 119.02 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.12 110.918 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 p -106.66 153.75 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 52.45 110.854 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 35.74 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 64.34 110.831 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.1 -74.26 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 72.14 112.47 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.09 164.59 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 73.51 110.932 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -51.54 -35.65 41.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 71.05 110.874 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.25 138.51 14.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 70.13 112.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -52.01 130.57 30.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 64.43 110.899 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.08 175.49 30.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 51.32 112.49 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -106.14 134.42 49.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 73.31 110.933 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.887 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.612 0.72 . . . . 63.22 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.01 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.634 2.222 . . . . 74.43 112.373 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.54 158.53 1.46 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.576 0.703 . . . . 73.14 110.87 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 -34.6 13.84 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.65 2.233 . . . . 64.24 112.339 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.2 120.43 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.102 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.76 163.12 14.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 75.55 110.974 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -123.88 -57.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.02 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.5 174.78 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.17 160.53 78.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.581 0.705 . . . . 72.41 110.872 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 170.17 17.16 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.669 2.246 . . . . 62.03 112.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.56 -51.51 4.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.738 . . . . 63.45 112.505 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -64.83 147.68 52.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 70.54 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 p -83.66 143.34 30.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.137 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t -87.24 149.7 24.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.55 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -135.48 138.74 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.52 110.896 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 ttp85 -105.09 37.79 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.889 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.98 -78.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 71.24 112.481 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.5 mt -52.56 164.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 55.55 110.912 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -35.72 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.868 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.59 140.65 15.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.481 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -52.02 123.91 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 75.54 110.926 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.62 171.77 21.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.713 -0.756 . . . . 43.42 112.48 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -105.71 129.59 53.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 73.51 110.861 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 55.23 110.89 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.686 0.755 . . . . 73.32 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 84.68 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 74.43 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -114.31 73.43 2.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.732 . . . . 71.23 110.879 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -33.15 17.28 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 45.13 112.352 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -67.6 146.59 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.32 111.117 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.14 98.13 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 64.13 110.925 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.33 -51.19 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 64.13 111.162 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.57 171.44 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 51.53 110.837 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -91.06 159.01 40.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.624 0.726 . . . . 63.43 110.854 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.52 16.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.652 2.235 . . . . 74.21 112.326 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.46 -49.5 3.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 71.22 112.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.66 144.71 57.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.44 110.892 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -84.51 144.71 28.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.42 111.146 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.5 t -79.33 140.98 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 72.5 110.834 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 p -119.45 147.45 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 72.21 110.88 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -102.03 133.75 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.886 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.89 -89.44 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 71.02 112.477 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.02 165.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 71.45 110.896 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -49.12 -34.26 13.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 65.33 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.66 149.97 17.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.696 -0.764 . . . . 60.45 112.491 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -51.55 132.69 30.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 74.02 110.911 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.4 165.63 12.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.69 -0.767 . . . . 72.44 112.478 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.6 p -120.06 113.02 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.25 110.921 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.879 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.643 0.735 . . . . 72.42 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -46.43 1.26 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 73.31 112.385 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -145.44 68.44 13.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 74.41 110.865 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 176.5 6.68 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.655 2.236 . . . . 73.41 112.388 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.66 147.06 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 73.52 111.161 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.35 98.16 8.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.948 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -135.77 -41.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 70.33 111.106 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.04 -179.86 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 72.03 110.858 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -95.29 159.3 33.14 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.565 0.697 . . . . 61.21 110.878 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 163.07 39.66 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.688 2.259 . . . . 75.21 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -45.8 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 71.15 112.48 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.18 144.54 57.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 54.2 110.923 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -94.2 144.94 25.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 62.03 111.178 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 t -79.17 133.2 36.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.14 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.99 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 43.31 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttp85 -102.6 41.81 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.57 -78.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 71.25 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.77 165.14 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 73.14 110.883 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -49.8 -34.55 19.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 54.2 110.837 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.43 141.51 15.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 44.32 112.483 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.67 126.36 17.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.944 0.402 . . . . 75.41 110.88 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.06 167.56 18.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 65.13 112.463 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 p -121.52 119.72 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 63.32 110.875 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.883 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.688 0.756 . . . . 65.54 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 133.93 26.93 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 75.32 112.357 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.61 160.14 48.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 73.41 110.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -39.9 5.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 54.3 112.33 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.82 112.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.54 111.101 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -84.93 100.53 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.52 110.922 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -125.86 -42.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 75.33 111.154 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.57 178.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.867 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.85 157.61 59.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.578 0.704 . . . . 74.31 110.877 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 162.57 41.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.649 2.233 . . . . 73.13 112.33 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.59 3.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 52.13 112.483 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -64.67 143.53 57.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.878 0.371 . . . . 62.11 110.907 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 t -83.79 139.18 32.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.12 136.67 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.4 110.855 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.06 151.33 50.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.892 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 37.06 3.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 64.35 110.862 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.84 -82.56 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 53.22 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 164.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.375 . . . . 71.23 110.9 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -50.45 -34.96 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.14 142.14 15.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.667 -0.778 . . . . 71.21 112.458 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.55 133.9 52.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 74.33 110.954 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.91 175.44 29.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 73.1 112.464 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.0 p -114.98 122.02 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 70.52 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.86 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.629 0.728 . . . . 74.33 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -33.58 16.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.64 2.226 . . . . 74.4 112.325 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.02 160.52 78.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 61.51 110.839 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -42.48 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.236 . . . . 75.32 112.312 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.41 145.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 65.1 111.095 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -129.73 104.75 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 72.33 110.923 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -111.33 -35.78 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 53.44 111.128 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.36 168.56 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 63.52 110.935 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -83.85 159.15 61.01 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.71 . . . . 74.44 110.892 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 169.77 18.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 74.34 112.323 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.56 -50.29 4.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 62.52 112.53 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -64.66 152.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 71.45 110.92 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 t -88.59 144.63 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.45 111.11 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.73 132.77 34.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 62.1 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.9 p -113.29 143.85 43.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.01 110.887 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -110.34 51.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.825 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.08 -78.74 1.15 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 63.35 112.484 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -51.62 165.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 74.04 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -49.07 -34.27 13.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 73.05 110.85 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.51 -172.25 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 60.24 112.485 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -89.69 127.7 35.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 71.03 110.902 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.24 175.35 19.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 72.3 112.458 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 p -119.14 124.71 47.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.367 . . . . 61.04 110.852 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.838 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.666 0.746 . . . . 65.5 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -37.53 9.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.252 . . . . 72.44 112.376 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.21 68.16 0.2 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 62.41 110.834 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 73.31 112.364 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.26 150.22 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.142 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 98.1 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.94 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.53 -52.89 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 62.1 111.105 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 m -67.49 169.74 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 42.31 110.878 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 155.86 67.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 73.34 110.909 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 155.95 64.46 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.722 2.282 . . . . 73.14 112.317 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.54 -48.89 3.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.511 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.45 129.93 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 75.22 110.899 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -85.82 144.78 27.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.148 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -79.25 131.9 36.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 64.35 110.907 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.11 153.78 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 51.24 110.862 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -107.92 40.58 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.1 110.836 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.28 -81.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 72.33 112.471 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.86 164.84 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 73.12 110.86 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -50.73 -35.12 29.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.894 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.39 144.69 15.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.483 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -51.86 127.39 20.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 62.23 110.938 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.93 175.54 21.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 71.22 112.491 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.83 123.32 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 70.21 110.893 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 70.04 110.865 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.609 0.719 . . . . 44.32 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.259 . . . . 65.34 112.356 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -117.65 68.68 6.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 71.12 110.857 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 54.24 112.351 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.91 149.89 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.24 111.092 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.11 98.4 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.933 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -130.55 -49.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 70.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.21 -174.36 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 157.61 50.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 72.44 110.854 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.89 26.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 71.03 112.319 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 -49.85 4.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 41.22 112.49 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -64.84 144.95 56.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.914 0.388 . . . . 71.33 110.861 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -85.19 144.57 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.23 111.151 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -79.38 140.42 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.861 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.17 138.65 51.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.891 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -109.9 54.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.76 1.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 52.42 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.6 165.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 74.43 110.937 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -49.41 -34.47 16.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.02 110.828 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.17 -174.77 31.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 71.14 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.7 129.41 36.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.925 0.393 . . . . 75.33 110.909 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.22 168.7 20.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 72.04 112.525 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -117.86 115.59 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 64.33 110.905 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 31.25 110.871 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.651 0.738 . . . . 54.14 110.859 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -33.43 16.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.727 2.285 . . . . 60.44 112.314 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.99 160.49 1.15 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.644 0.735 . . . . 75.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.656 2.238 . . . . 74.25 112.337 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.34 148.91 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.098 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.44 102.81 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.926 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -52.3 -36.55 53.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.33 111.186 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.27 179.68 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 34.01 110.872 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.56 69.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.542 0.687 . . . . 75.12 110.917 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 161.51 45.62 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 72.4 112.373 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.37 -49.53 3.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 54.31 112.465 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -65.42 143.84 57.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 75.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -86.66 136.57 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.108 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -83.19 131.74 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 63.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.23 156.15 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.45 51.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.897 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.43 -32.9 36.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 71.21 112.506 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.26 165.55 11.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -48.05 -34.32 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.84 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.15 138.22 14.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 63.14 112.478 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -52.05 128.88 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 64.22 110.905 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.0 175.55 21.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 73.22 112.461 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.3 p -114.04 129.29 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 51.03 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.4 110.894 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.61 0.719 . . . . 73.34 110.836 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.625 2.216 . . . . 74.55 112.311 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.04 160.54 27.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 72.25 110.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -33.05 17.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.698 2.265 . . . . 62.13 112.357 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.38 149.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 54.31 111.148 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -71.72 99.75 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 75.45 110.888 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -110.86 -39.58 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.516 . . . . 75.41 111.155 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 89.6 m -74.33 -175.22 2.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.851 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -111.25 157.24 39.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 73.24 110.879 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 160.81 48.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.258 . . . . 64.14 112.341 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 -48.99 3.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 70.24 112.494 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.65 149.06 49.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 71.33 110.902 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 62.44 111.195 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -79.1 129.09 34.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 74.45 110.888 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.13 161.19 22.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 34.03 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.19 47.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.876 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.65 -88.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 54.41 112.526 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.55 165.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.792 0.329 . . . . 71.31 110.961 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -49.06 -34.37 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.05 110.846 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.65 17.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 63.43 112.471 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -51.89 130.09 28.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 72.11 110.93 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.15 166.08 24.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.505 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.4 p -119.9 113.05 19.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 24.4 110.873 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 61.02 110.846 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.661 0.744 . . . . 45.34 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.25 16.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.719 2.279 . . . . 73.15 112.361 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.97 160.57 1.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.561 0.696 . . . . 53.54 110.88 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.84 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 62.04 112.36 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.37 143.41 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -120.34 163.69 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 71.22 110.922 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -51.79 -35.84 45.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 62.11 111.173 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.2 m -52.94 169.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 51.21 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -93.64 159.22 35.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 65.24 110.838 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.99 10.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 75.42 112.32 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -50.48 4.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 53.54 112.47 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -64.64 149.84 48.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.42 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -82.64 142.42 31.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.52 111.121 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -82.43 132.85 35.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 71.44 110.888 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.76 143.16 45.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.873 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -109.44 37.2 2.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.44 110.9 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 32.04 112.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -51.94 164.47 0.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 73.13 110.933 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.97 -35.93 47.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 71.03 110.863 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 138.54 14.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 64.35 112.53 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -52.34 129.27 27.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.915 0.388 . . . . 75.04 110.886 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.92 175.04 21.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 62.41 112.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.9 p -104.93 136.97 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 72.53 110.888 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 71.51 110.863 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.616 0.722 . . . . 64.11 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.88 17.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 70.24 112.346 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -173.14 65.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 62.22 110.844 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.675 2.25 . . . . 72.35 112.344 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' VAL . 8.3 m -101.77 107.39 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.31 111.144 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -130.84 164.04 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.04 110.886 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.3 p -51.69 -34.54 38.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.107 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.44 -171.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -111.02 160.97 26.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.616 0.722 . . . . 75.22 110.847 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 64.52 112.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.78 -45.88 3.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 41.22 112.479 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.13 152.2 41.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.396 . . . . 73.12 110.901 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 t -81.39 144.82 31.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 72.14 111.15 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.4 t -79.41 140.43 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.12 110.906 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.16 136.63 53.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 42.54 110.933 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.25 35.64 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.3 110.892 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.62 -64.23 3.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 60.41 112.466 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.92 165.08 25.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 74.35 110.917 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -49.75 -34.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.87 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.91 140.72 16.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 42.31 112.511 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -51.54 133.05 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.399 . . . . 73.42 110.901 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.66 175.61 20.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 51.21 112.508 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -98.38 129.81 45.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 65.31 110.881 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 64.22 110.865 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.665 0.745 . . . . 74.22 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 79.12 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 64.41 112.353 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -116.77 73.41 6.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.71 . . . . 54.52 110.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.15 17.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.25 . . . . 61.52 112.361 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.95 145.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -72.4 103.91 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.941 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -118.34 -47.18 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 54.32 111.096 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 m -113.21 171.17 7.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 64.42 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.63 160.57 50.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 72.25 110.902 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.21 28.35 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.673 2.249 . . . . 74.02 112.38 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.48 -49.55 3.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.72 . . . . 74.22 112.493 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.34 143.58 56.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.927 0.394 . . . . 71.31 110.9 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -87.54 136.64 32.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.172 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.66 132.51 35.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 64.2 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -126.52 147.33 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.919 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -105.11 35.8 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.08 -80.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 71.12 112.511 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -51.94 164.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 64.35 110.939 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -51.09 -35.17 33.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 63.5 110.88 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.58 139.5 14.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 62.41 112.488 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -51.92 130.06 28.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 71.31 110.923 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.18 175.39 26.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 31.45 112.499 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -114.47 133.15 55.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 53.25 110.929 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 60.13 110.847 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.607 0.717 . . . . 74.31 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -34.26 15.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.704 2.27 . . . . 72.41 112.35 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.76 160.71 1.02 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.43 110.902 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 77.99 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.747 2.298 . . . . 70.12 112.323 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 21' ' ' TYR . 17.9 m -101.64 150.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.121 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.15 98.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.94 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -51.66 126.12 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 71.41 111.113 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 m -89.68 -169.54 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.34 110.853 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -60.76 160.6 18.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.633 0.73 . . . . 72.51 110.861 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.84 55.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 73.4 112.338 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 -47.64 3.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 72.41 112.471 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.32 151.95 42.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.352 . . . . 62.51 110.919 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -108.54 145.16 35.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.22 111.132 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.3 t -78.81 114.14 17.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 44.32 110.906 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.96 161.18 14.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 53.23 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -123.6 143.38 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.867 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.95 -32.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 33.12 112.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 166.29 10.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.355 . . . . 75.5 110.877 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -46.5 -34.64 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 65.24 110.845 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.26 14.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 62.24 112.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 5' ' ' VAL . 11.7 m-85 -51.67 142.14 15.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 70.44 110.916 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.04 169.48 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 30.42 112.48 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 p -125.12 112.94 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.876 0.369 . . . . 72.41 110.899 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.883 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.593 0.711 . . . . 61.33 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.56 18.15 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.223 . . . . 74.43 112.378 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.19 158.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.617 0.722 . . . . 74.53 110.861 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 165.98 29.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.682 2.255 . . . . 63.02 112.361 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.7 p -55.25 122.95 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.02 111.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -119.26 143.79 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 71.22 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -53.44 123.25 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.145 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.23 175.77 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.926 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -107.22 157.65 34.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.657 0.741 . . . . 74.54 110.812 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 158.26 57.58 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.698 2.265 . . . . 54.11 112.321 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -48.09 3.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 23.0 112.549 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.49 127.27 30.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 75.25 110.888 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -83.62 145.05 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 62.12 111.167 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.2 t -78.96 114.12 17.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 p -121.66 170.34 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 64.24 110.919 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.22 33.63 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.863 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.31 -70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 71.14 112.472 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.6 mt -58.72 165.03 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 74.14 110.918 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -50.15 -34.74 23.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.833 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.89 138.49 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 63.43 112.434 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -51.86 129.78 27.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 74.2 110.908 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.07 175.58 29.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 74.4 112.503 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.8 p -106.1 127.93 53.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.12 110.845 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 51.35 110.83 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.652 0.739 . . . . 31.03 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -40.57 5.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 53.15 112.335 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.11 160.56 2.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.595 0.712 . . . . 65.54 110.854 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -44.05 2.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.687 2.258 . . . . 64.25 112.389 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.31 133.23 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 44.35 111.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.24 125.9 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 71.03 110.935 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -84.16 -36.04 23.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 63.34 111.169 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.45 179.71 4.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.1 110.875 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -66.76 160.63 67.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 71.45 110.888 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 157.07 61.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 61.42 112.305 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.57 3.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 62.0 112.49 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -64.62 140.34 58.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 60.54 110.922 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -87.73 144.55 26.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 75.53 111.09 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.99 127.53 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.888 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -120.8 141.98 50.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 44.51 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -99.56 35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.42 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.5 -81.43 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.762 . . . . 41.55 112.47 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -51.91 164.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.793 0.33 . . . . 74.03 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -51.23 -35.43 36.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 72.41 110.852 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.05 140.42 15.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 63.1 112.508 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -51.83 126.24 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 71.43 110.985 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.2 175.52 20.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 73.14 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.36 115.34 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 63.23 110.904 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.1 110.836 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.629 0.728 . . . . 72.43 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 91.67 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.664 2.243 . . . . 72.54 112.364 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -133.47 160.58 68.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.591 0.71 . . . . 62.21 110.917 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -44.94 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.728 2.285 . . . . 72.11 112.337 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.05 134.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 62.15 111.122 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -90.64 142.51 27.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.489 . . . . 73.43 110.932 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -110.02 -64.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 51.24 111.152 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 m -81.74 179.2 7.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.11 110.839 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -77.5 160.6 74.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 71.55 110.861 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.94 51.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 61.24 112.359 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -49.59 3.91 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 73.5 112.455 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -65.12 149.57 49.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 74.3 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -90.39 137.05 32.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 65.11 111.165 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.1 127.92 35.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.9 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -123.87 149.98 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.62 38.49 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.894 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.33 -64.59 2.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.732 -0.746 . . . . 53.24 112.49 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.97 164.73 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.899 0.381 . . . . 74.34 110.898 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -51.18 -35.38 35.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.869 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.53 138.43 14.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 64.14 112.492 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.0 127.79 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 73.33 110.931 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.99 175.4 27.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.756 -0.735 . . . . 75.44 112.508 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 p -112.63 127.62 56.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 65.33 110.879 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.887 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 63.41 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 145.16 56.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.255 . . . . 41.13 112.323 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.27 160.08 1.18 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 74.31 110.85 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -43.33 2.7 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.678 2.252 . . . . 62.4 112.334 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.06 149.18 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.42 111.095 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -72.06 114.96 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 61.25 110.936 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -70.24 177.71 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 53.45 111.138 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.0 m -70.94 -175.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 45.21 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -61.4 160.6 23.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.573 0.701 . . . . 75.53 110.904 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 169.58 18.54 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.725 2.283 . . . . 72.53 112.373 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -50.35 4.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 43.15 112.512 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.96 151.59 45.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 74.41 110.946 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 t -82.87 143.87 30.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t -94.04 148.12 22.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 41.01 110.851 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.2 p -130.49 141.78 50.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.91 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -111.1 37.74 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.31 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 -77.75 0.54 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.725 -0.75 . . . . 45.12 112.491 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -51.95 164.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 73.24 110.893 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -51.97 -35.92 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 74.51 110.873 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.95 138.7 14.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 52.13 112.509 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -52.91 132.36 37.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 72.4 110.913 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.82 170.19 25.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 41.14 112.499 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.6 p -99.19 140.52 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 52.21 110.889 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 65.23 110.822 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.624 0.726 . . . . 64.11 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -33.23 17.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.662 2.241 . . . . 72.11 112.343 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 5' ' ' VAL . 6.6 m-20 -51.97 160.59 1.12 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 75.45 110.919 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -33.12 17.26 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.725 2.283 . . . . 71.32 112.327 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 3' ' ' ASP . 17.5 m -55.36 121.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 63.12 111.095 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.5 123.68 49.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.912 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -100.96 -37.99 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 51.21 111.144 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -120.8 175.11 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.34 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -63.35 159.1 52.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.741 . . . . 74.33 110.85 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 167.9 23.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.654 2.236 . . . . 71.22 112.346 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.51 -51.31 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 60.02 112.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.67 144.62 57.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 53.04 110.89 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -82.29 144.56 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 71.23 111.166 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.55 117.92 27.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.918 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.1 p -98.92 139.35 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -100.31 35.74 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.41 -82.65 0.16 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 73.14 112.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.4 mt -51.88 164.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 64.23 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -51.47 -35.5 40.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.864 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.63 140.79 15.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 51.33 112.469 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -52.0 125.0 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 75.24 110.951 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.3 175.47 20.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 44.43 112.496 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -106.57 132.73 52.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 63.43 110.85 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.883 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.616 0.722 . . . . 71.54 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 82.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.25 . . . . 75.4 112.355 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.0 160.52 30.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 61.54 110.87 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -48.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.723 2.282 . . . . 62.23 112.335 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.49 150.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.34 111.133 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.0 107.92 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 71.1 110.912 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -96.81 -37.26 10.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 62.41 111.144 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.3 m -106.73 179.5 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.879 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -97.83 160.54 28.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 60.25 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 163.38 38.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 64.11 112.388 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -49.45 3.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 71.31 112.492 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -65.55 136.1 55.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 64.44 110.919 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -83.01 139.84 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -79.43 114.21 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 75.51 110.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.32 143.84 27.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.885 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -103.98 38.85 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.859 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.47 -82.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.486 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.4 mp -51.88 164.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.42 110.949 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -51.57 -35.62 41.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.827 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.2 138.64 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.479 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -51.96 123.32 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 73.44 110.924 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.22 175.51 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 75.4 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 p -114.69 121.02 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 74.24 110.858 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 52.24 110.912 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.627 0.727 . . . . 50.35 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 95.89 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.701 2.268 . . . . 72.13 112.328 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.54 160.04 1.11 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.568 0.699 . . . . 72.05 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -48.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.246 . . . . 71.13 112.317 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -101.51 150.14 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.55 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -97.62 160.47 14.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.918 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -118.18 -66.11 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 64.11 111.138 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 m -60.85 -179.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.14 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -74.09 160.56 81.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 73.24 110.85 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 159.31 53.9 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.702 2.268 . . . . 64.04 112.304 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.02 -51.27 4.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 52.03 112.432 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.59 128.76 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 61.44 110.899 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -81.51 144.7 31.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.32 111.12 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -83.89 119.02 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.12 110.918 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 p -106.66 153.75 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 52.45 110.854 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 35.74 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 64.34 110.831 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.1 -74.26 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 72.14 112.47 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.09 164.59 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 73.51 110.932 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -51.54 -35.65 41.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 71.05 110.874 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.25 138.51 14.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 70.13 112.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -52.01 130.57 30.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 64.43 110.899 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.08 175.49 30.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 51.32 112.49 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -106.14 134.42 49.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 73.31 110.933 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.887 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.612 0.72 . . . . 63.22 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.01 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.634 2.222 . . . . 74.43 112.373 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.54 158.53 1.46 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.576 0.703 . . . . 73.14 110.87 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 -34.6 13.84 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.65 2.233 . . . . 64.24 112.339 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.2 120.43 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.102 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.76 163.12 14.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 75.55 110.974 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -123.88 -57.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.02 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.5 174.78 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.17 160.53 78.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.581 0.705 . . . . 72.41 110.872 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 170.17 17.16 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.669 2.246 . . . . 62.03 112.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.56 -51.51 4.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.738 . . . . 63.45 112.505 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -64.83 147.68 52.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 70.54 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 p -83.66 143.34 30.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.137 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t -87.24 149.7 24.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.55 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -135.48 138.74 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.52 110.896 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 ttp85 -105.09 37.79 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.889 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.98 -78.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 71.24 112.481 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.5 mt -52.56 164.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 55.55 110.912 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -35.72 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.868 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.59 140.65 15.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.481 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -52.02 123.91 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 75.54 110.926 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.62 171.77 21.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.713 -0.756 . . . . 43.42 112.48 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -105.71 129.59 53.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 73.51 110.861 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 55.23 110.89 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.686 0.755 . . . . 73.32 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 84.68 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 74.43 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -114.31 73.43 2.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.732 . . . . 71.23 110.879 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -33.15 17.28 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 45.13 112.352 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -67.6 146.59 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.32 111.117 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.14 98.13 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 64.13 110.925 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.33 -51.19 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 64.13 111.162 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.57 171.44 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 51.53 110.837 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -91.06 159.01 40.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.624 0.726 . . . . 63.43 110.854 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.52 16.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.652 2.235 . . . . 74.21 112.326 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.46 -49.5 3.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 71.22 112.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.66 144.71 57.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.44 110.892 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -84.51 144.71 28.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.42 111.146 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.5 t -79.33 140.98 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 72.5 110.834 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 p -119.45 147.45 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 72.21 110.88 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -102.03 133.75 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.886 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.89 -89.44 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 71.02 112.477 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.02 165.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 71.45 110.896 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -49.12 -34.26 13.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 65.33 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.66 149.97 17.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.696 -0.764 . . . . 60.45 112.491 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -51.55 132.69 30.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 74.02 110.911 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.4 165.63 12.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.69 -0.767 . . . . 72.44 112.478 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.6 p -120.06 113.02 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.25 110.921 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.879 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.643 0.735 . . . . 72.42 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -46.43 1.26 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 73.31 112.385 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -145.44 68.44 13.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 74.41 110.865 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 176.5 6.68 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.655 2.236 . . . . 73.41 112.388 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.66 147.06 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 73.52 111.161 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.35 98.16 8.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.948 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -135.77 -41.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 70.33 111.106 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.04 -179.86 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 72.03 110.858 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -95.29 159.3 33.14 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.565 0.697 . . . . 61.21 110.878 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 163.07 39.66 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.688 2.259 . . . . 75.21 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -45.8 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 71.15 112.48 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.18 144.54 57.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 54.2 110.923 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -94.2 144.94 25.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 62.03 111.178 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 t -79.17 133.2 36.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.14 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.99 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 43.31 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttp85 -102.6 41.81 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.57 -78.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 71.25 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.77 165.14 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 73.14 110.883 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -49.8 -34.55 19.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 54.2 110.837 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.43 141.51 15.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 44.32 112.483 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.67 126.36 17.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.944 0.402 . . . . 75.41 110.88 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.06 167.56 18.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 65.13 112.463 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 p -121.52 119.72 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 63.32 110.875 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.883 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.688 0.756 . . . . 65.54 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 133.93 26.93 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 75.32 112.357 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.61 160.14 48.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 73.41 110.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -39.9 5.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 54.3 112.33 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.82 112.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.54 111.101 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -84.93 100.53 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.52 110.922 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -125.86 -42.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 75.33 111.154 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.57 178.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.867 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.85 157.61 59.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.578 0.704 . . . . 74.31 110.877 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 162.57 41.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.649 2.233 . . . . 73.13 112.33 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.59 3.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 52.13 112.483 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -64.67 143.53 57.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.878 0.371 . . . . 62.11 110.907 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 t -83.79 139.18 32.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.12 136.67 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.4 110.855 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.06 151.33 50.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.892 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 37.06 3.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 64.35 110.862 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.84 -82.56 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 53.22 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 164.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.375 . . . . 71.23 110.9 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -50.45 -34.96 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.14 142.14 15.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.667 -0.778 . . . . 71.21 112.458 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.55 133.9 52.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 74.33 110.954 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.91 175.44 29.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 73.1 112.464 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.0 p -114.98 122.02 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 70.52 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.86 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.629 0.728 . . . . 74.33 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -33.58 16.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.64 2.226 . . . . 74.4 112.325 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.02 160.52 78.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 61.51 110.839 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -42.48 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.236 . . . . 75.32 112.312 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.41 145.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 65.1 111.095 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -129.73 104.75 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 72.33 110.923 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -111.33 -35.78 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 53.44 111.128 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.36 168.56 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 63.52 110.935 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -83.85 159.15 61.01 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.71 . . . . 74.44 110.892 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 169.77 18.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 74.34 112.323 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.56 -50.29 4.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 62.52 112.53 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -64.66 152.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 71.45 110.92 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 t -88.59 144.63 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.45 111.11 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.73 132.77 34.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 62.1 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.9 p -113.29 143.85 43.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.01 110.887 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -110.34 51.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.825 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.08 -78.74 1.15 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 63.35 112.484 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -51.62 165.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 74.04 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -49.07 -34.27 13.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 73.05 110.85 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.51 -172.25 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 60.24 112.485 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -89.69 127.7 35.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 71.03 110.902 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.24 175.35 19.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 72.3 112.458 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 p -119.14 124.71 47.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.367 . . . . 61.04 110.852 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.838 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.666 0.746 . . . . 65.5 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -37.53 9.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.252 . . . . 72.44 112.376 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.21 68.16 0.2 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 62.41 110.834 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 73.31 112.364 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.26 150.22 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.142 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 98.1 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.94 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.53 -52.89 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 62.1 111.105 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 m -67.49 169.74 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 42.31 110.878 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 155.86 67.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 73.34 110.909 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 155.95 64.46 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.722 2.282 . . . . 73.14 112.317 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.54 -48.89 3.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.511 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.45 129.93 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 75.22 110.899 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -85.82 144.78 27.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.148 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -79.25 131.9 36.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 64.35 110.907 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.11 153.78 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 51.24 110.862 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -107.92 40.58 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.1 110.836 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.28 -81.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 72.33 112.471 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.86 164.84 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 73.12 110.86 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -50.73 -35.12 29.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.894 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.39 144.69 15.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.483 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -51.86 127.39 20.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 62.23 110.938 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.93 175.54 21.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 71.22 112.491 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.83 123.32 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 70.21 110.893 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 70.04 110.865 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.609 0.719 . . . . 44.32 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.259 . . . . 65.34 112.356 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -117.65 68.68 6.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 71.12 110.857 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 54.24 112.351 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.91 149.89 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.24 111.092 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.11 98.4 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.933 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -130.55 -49.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 70.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.21 -174.36 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 157.61 50.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 72.44 110.854 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.89 26.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 71.03 112.319 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 -49.85 4.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 41.22 112.49 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -64.84 144.95 56.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.914 0.388 . . . . 71.33 110.861 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -85.19 144.57 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.23 111.151 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -79.38 140.42 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.861 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.17 138.65 51.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.891 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -109.9 54.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.76 1.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 52.42 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.6 165.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 74.43 110.937 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -49.41 -34.47 16.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.02 110.828 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.17 -174.77 31.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 71.14 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.7 129.41 36.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.925 0.393 . . . . 75.33 110.909 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.22 168.7 20.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 72.04 112.525 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -117.86 115.59 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 64.33 110.905 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 31.25 110.871 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.651 0.738 . . . . 54.14 110.859 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -33.43 16.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.727 2.285 . . . . 60.44 112.314 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.99 160.49 1.15 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.644 0.735 . . . . 75.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.656 2.238 . . . . 74.25 112.337 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.34 148.91 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.098 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.44 102.81 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.926 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -52.3 -36.55 53.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.33 111.186 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.27 179.68 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 34.01 110.872 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.56 69.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.542 0.687 . . . . 75.12 110.917 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 161.51 45.62 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 72.4 112.373 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.37 -49.53 3.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 54.31 112.465 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -65.42 143.84 57.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 75.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -86.66 136.57 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.108 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -83.19 131.74 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 63.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.23 156.15 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.45 51.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.897 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.43 -32.9 36.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 71.21 112.506 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.26 165.55 11.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -48.05 -34.32 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.84 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.15 138.22 14.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 63.14 112.478 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -52.05 128.88 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 64.22 110.905 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.0 175.55 21.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 73.22 112.461 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.3 p -114.04 129.29 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 51.03 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.4 110.894 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.61 0.719 . . . . 73.34 110.836 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.625 2.216 . . . . 74.55 112.311 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.04 160.54 27.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 72.25 110.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -33.05 17.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.698 2.265 . . . . 62.13 112.357 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.38 149.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 54.31 111.148 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -71.72 99.75 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 75.45 110.888 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -110.86 -39.58 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.516 . . . . 75.41 111.155 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 89.6 m -74.33 -175.22 2.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.851 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -111.25 157.24 39.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 73.24 110.879 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 160.81 48.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.258 . . . . 64.14 112.341 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 -48.99 3.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 70.24 112.494 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.65 149.06 49.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 71.33 110.902 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 62.44 111.195 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -79.1 129.09 34.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 74.45 110.888 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.13 161.19 22.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 34.03 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.19 47.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.876 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.65 -88.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 54.41 112.526 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.55 165.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.792 0.329 . . . . 71.31 110.961 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -49.06 -34.37 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.05 110.846 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.65 17.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 63.43 112.471 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -51.89 130.09 28.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 72.11 110.93 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.15 166.08 24.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.505 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.4 p -119.9 113.05 19.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 24.4 110.873 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 61.02 110.846 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.661 0.744 . . . . 45.34 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.25 16.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.719 2.279 . . . . 73.15 112.361 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.97 160.57 1.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.561 0.696 . . . . 53.54 110.88 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.84 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 62.04 112.36 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.37 143.41 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -120.34 163.69 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 71.22 110.922 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -51.79 -35.84 45.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 62.11 111.173 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.2 m -52.94 169.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 51.21 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -93.64 159.22 35.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 65.24 110.838 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.99 10.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 75.42 112.32 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -50.48 4.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 53.54 112.47 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -64.64 149.84 48.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.42 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -82.64 142.42 31.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.52 111.121 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -82.43 132.85 35.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 71.44 110.888 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.76 143.16 45.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.873 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -109.44 37.2 2.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.44 110.9 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 32.04 112.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -51.94 164.47 0.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 73.13 110.933 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.97 -35.93 47.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 71.03 110.863 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 138.54 14.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 64.35 112.53 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -52.34 129.27 27.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.915 0.388 . . . . 75.04 110.886 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.92 175.04 21.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 62.41 112.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.9 p -104.93 136.97 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 72.53 110.888 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 71.51 110.863 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.616 0.722 . . . . 64.11 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.88 17.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 70.24 112.346 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -173.14 65.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 62.22 110.844 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.675 2.25 . . . . 72.35 112.344 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' VAL . 8.3 m -101.77 107.39 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.31 111.144 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -130.84 164.04 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.04 110.886 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.3 p -51.69 -34.54 38.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.107 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.44 -171.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -111.02 160.97 26.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.616 0.722 . . . . 75.22 110.847 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 64.52 112.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.78 -45.88 3.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 41.22 112.479 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.13 152.2 41.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.396 . . . . 73.12 110.901 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 t -81.39 144.82 31.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 72.14 111.15 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.4 t -79.41 140.43 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.12 110.906 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.16 136.63 53.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 42.54 110.933 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.25 35.64 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.3 110.892 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.62 -64.23 3.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 60.41 112.466 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.92 165.08 25.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 74.35 110.917 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -49.75 -34.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.87 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.91 140.72 16.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 42.31 112.511 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -51.54 133.05 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.399 . . . . 73.42 110.901 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.66 175.61 20.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 51.21 112.508 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -98.38 129.81 45.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 65.31 110.881 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 64.22 110.865 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.665 0.745 . . . . 74.22 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 79.12 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 64.41 112.353 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -116.77 73.41 6.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.71 . . . . 54.52 110.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.15 17.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.25 . . . . 61.52 112.361 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.95 145.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -72.4 103.91 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.941 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -118.34 -47.18 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 54.32 111.096 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 m -113.21 171.17 7.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 64.42 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.63 160.57 50.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 72.25 110.902 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.21 28.35 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.673 2.249 . . . . 74.02 112.38 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.48 -49.55 3.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.72 . . . . 74.22 112.493 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.34 143.58 56.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.927 0.394 . . . . 71.31 110.9 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -87.54 136.64 32.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.172 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.66 132.51 35.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 64.2 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -126.52 147.33 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.919 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -105.11 35.8 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.08 -80.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 71.12 112.511 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -51.94 164.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 64.35 110.939 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -51.09 -35.17 33.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 63.5 110.88 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.58 139.5 14.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 62.41 112.488 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -51.92 130.06 28.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 71.31 110.923 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.18 175.39 26.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 31.45 112.499 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -114.47 133.15 55.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 53.25 110.929 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 60.13 110.847 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.607 0.717 . . . . 74.31 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -34.26 15.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.704 2.27 . . . . 72.41 112.35 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.76 160.71 1.02 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.43 110.902 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 77.99 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.747 2.298 . . . . 70.12 112.323 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 21' ' ' TYR . 17.9 m -101.64 150.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.121 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.15 98.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.94 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -51.66 126.12 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 71.41 111.113 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 m -89.68 -169.54 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.34 110.853 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -60.76 160.6 18.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.633 0.73 . . . . 72.51 110.861 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.84 55.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 73.4 112.338 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 -47.64 3.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 72.41 112.471 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.32 151.95 42.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.352 . . . . 62.51 110.919 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -108.54 145.16 35.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.22 111.132 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.3 t -78.81 114.14 17.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 44.32 110.906 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.96 161.18 14.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 53.23 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -123.6 143.38 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.867 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.95 -32.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 33.12 112.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 166.29 10.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.355 . . . . 75.5 110.877 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -46.5 -34.64 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 65.24 110.845 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.26 14.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 62.24 112.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 5' ' ' VAL . 11.7 m-85 -51.67 142.14 15.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 70.44 110.916 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.04 169.48 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 30.42 112.48 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 p -125.12 112.94 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.876 0.369 . . . . 72.41 110.899 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.883 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.593 0.711 . . . . 61.33 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.56 18.15 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.223 . . . . 74.43 112.378 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.19 158.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.617 0.722 . . . . 74.53 110.861 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 165.98 29.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.682 2.255 . . . . 63.02 112.361 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.7 p -55.25 122.95 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.02 111.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -119.26 143.79 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 71.22 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -53.44 123.25 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.145 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.23 175.77 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.926 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -107.22 157.65 34.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.657 0.741 . . . . 74.54 110.812 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 158.26 57.58 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.698 2.265 . . . . 54.11 112.321 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -48.09 3.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 23.0 112.549 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.49 127.27 30.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 75.25 110.888 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -83.62 145.05 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 62.12 111.167 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.2 t -78.96 114.12 17.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 p -121.66 170.34 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 64.24 110.919 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.22 33.63 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.863 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.31 -70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 71.14 112.472 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.6 mt -58.72 165.03 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 74.14 110.918 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -50.15 -34.74 23.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.833 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.89 138.49 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 63.43 112.434 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -51.86 129.78 27.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 74.2 110.908 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.07 175.58 29.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 74.4 112.503 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.8 p -106.1 127.93 53.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.12 110.845 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 51.35 110.83 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.652 0.739 . . . . 31.03 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -40.57 5.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 53.15 112.335 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.11 160.56 2.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.595 0.712 . . . . 65.54 110.854 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -44.05 2.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.687 2.258 . . . . 64.25 112.389 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.31 133.23 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 44.35 111.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.24 125.9 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 71.03 110.935 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -84.16 -36.04 23.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 63.34 111.169 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.45 179.71 4.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.1 110.875 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -66.76 160.63 67.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 71.45 110.888 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 157.07 61.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 61.42 112.305 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.57 3.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 62.0 112.49 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -64.62 140.34 58.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 60.54 110.922 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -87.73 144.55 26.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 75.53 111.09 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.99 127.53 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.888 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -120.8 141.98 50.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 44.51 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -99.56 35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.42 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.5 -81.43 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.762 . . . . 41.55 112.47 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -51.91 164.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.793 0.33 . . . . 74.03 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -51.23 -35.43 36.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 72.41 110.852 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.05 140.42 15.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 63.1 112.508 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -51.83 126.24 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 71.43 110.985 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.2 175.52 20.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 73.14 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.36 115.34 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 63.23 110.904 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.1 110.836 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.629 0.728 . . . . 72.43 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 91.67 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.664 2.243 . . . . 72.54 112.364 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -133.47 160.58 68.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.591 0.71 . . . . 62.21 110.917 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -44.94 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.728 2.285 . . . . 72.11 112.337 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.05 134.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 62.15 111.122 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -90.64 142.51 27.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.489 . . . . 73.43 110.932 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -110.02 -64.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 51.24 111.152 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 m -81.74 179.2 7.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.11 110.839 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -77.5 160.6 74.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 71.55 110.861 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.94 51.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 61.24 112.359 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -49.59 3.91 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 73.5 112.455 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -65.12 149.57 49.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 74.3 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -90.39 137.05 32.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 65.11 111.165 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.1 127.92 35.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.9 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -123.87 149.98 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.62 38.49 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.894 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.33 -64.59 2.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.732 -0.746 . . . . 53.24 112.49 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.97 164.73 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.899 0.381 . . . . 74.34 110.898 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -51.18 -35.38 35.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.869 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.53 138.43 14.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 64.14 112.492 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.0 127.79 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 73.33 110.931 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.99 175.4 27.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.756 -0.735 . . . . 75.44 112.508 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 p -112.63 127.62 56.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 65.33 110.879 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.887 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 63.41 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 145.16 56.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.255 . . . . 41.13 112.323 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.27 160.08 1.18 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 74.31 110.85 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -43.33 2.7 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.678 2.252 . . . . 62.4 112.334 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.06 149.18 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.42 111.095 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -72.06 114.96 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 61.25 110.936 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -70.24 177.71 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 53.45 111.138 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.0 m -70.94 -175.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 45.21 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -61.4 160.6 23.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.573 0.701 . . . . 75.53 110.904 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 169.58 18.54 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.725 2.283 . . . . 72.53 112.373 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -50.35 4.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 43.15 112.512 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.96 151.59 45.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 74.41 110.946 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 t -82.87 143.87 30.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t -94.04 148.12 22.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 41.01 110.851 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.2 p -130.49 141.78 50.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.91 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -111.1 37.74 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.31 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 -77.75 0.54 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.725 -0.75 . . . . 45.12 112.491 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -51.95 164.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 73.24 110.893 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -51.97 -35.92 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 74.51 110.873 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.95 138.7 14.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 52.13 112.509 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -52.91 132.36 37.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 72.4 110.913 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.82 170.19 25.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 41.14 112.499 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.6 p -99.19 140.52 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 52.21 110.889 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 65.23 110.822 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.624 0.726 . . . . 64.11 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -33.23 17.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.662 2.241 . . . . 72.11 112.343 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 5' ' ' VAL . 6.6 m-20 -51.97 160.59 1.12 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 75.45 110.919 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -33.12 17.26 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.725 2.283 . . . . 71.32 112.327 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 3' ' ' ASP . 17.5 m -55.36 121.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 63.12 111.095 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.5 123.68 49.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.912 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -100.96 -37.99 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 51.21 111.144 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -120.8 175.11 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.34 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -63.35 159.1 52.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.741 . . . . 74.33 110.85 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 167.9 23.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.654 2.236 . . . . 71.22 112.346 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.51 -51.31 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 60.02 112.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.67 144.62 57.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 53.04 110.89 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -82.29 144.56 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 71.23 111.166 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.55 117.92 27.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.918 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.1 p -98.92 139.35 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -100.31 35.74 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.41 -82.65 0.16 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 73.14 112.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.4 mt -51.88 164.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 64.23 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -51.47 -35.5 40.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.864 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.63 140.79 15.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 51.33 112.469 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -52.0 125.0 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 75.24 110.951 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.3 175.47 20.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 44.43 112.496 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -106.57 132.73 52.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 63.43 110.85 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.883 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.616 0.722 . . . . 71.54 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 82.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.25 . . . . 75.4 112.355 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.0 160.52 30.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 61.54 110.87 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -48.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.723 2.282 . . . . 62.23 112.335 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.49 150.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.34 111.133 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.0 107.92 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 71.1 110.912 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -96.81 -37.26 10.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 62.41 111.144 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.3 m -106.73 179.5 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.879 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -97.83 160.54 28.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 60.25 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 163.38 38.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 64.11 112.388 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -49.45 3.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 71.31 112.492 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -65.55 136.1 55.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 64.44 110.919 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -83.01 139.84 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -79.43 114.21 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 75.51 110.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.32 143.84 27.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.885 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -103.98 38.85 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.859 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.47 -82.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.486 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.4 mp -51.88 164.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.42 110.949 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -51.57 -35.62 41.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.827 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.2 138.64 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.479 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -51.96 123.32 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 73.44 110.924 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.22 175.51 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 75.4 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 p -114.69 121.02 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 74.24 110.858 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 52.24 110.912 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.627 0.727 . . . . 50.35 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 95.89 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.701 2.268 . . . . 72.13 112.328 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.54 160.04 1.11 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.568 0.699 . . . . 72.05 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -48.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.246 . . . . 71.13 112.317 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -101.51 150.14 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.55 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -97.62 160.47 14.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.918 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -118.18 -66.11 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 64.11 111.138 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 m -60.85 -179.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.14 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -74.09 160.56 81.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 73.24 110.85 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 159.31 53.9 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.702 2.268 . . . . 64.04 112.304 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.02 -51.27 4.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 52.03 112.432 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.59 128.76 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 61.44 110.899 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -81.51 144.7 31.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.32 111.12 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -83.89 119.02 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.12 110.918 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 p -106.66 153.75 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 52.45 110.854 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 35.74 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 64.34 110.831 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.1 -74.26 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 72.14 112.47 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.09 164.59 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 73.51 110.932 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -51.54 -35.65 41.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 71.05 110.874 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.25 138.51 14.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 70.13 112.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -52.01 130.57 30.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 64.43 110.899 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.08 175.49 30.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 51.32 112.49 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -106.14 134.42 49.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 73.31 110.933 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.887 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.612 0.72 . . . . 63.22 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.01 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.634 2.222 . . . . 74.43 112.373 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.54 158.53 1.46 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.576 0.703 . . . . 73.14 110.87 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 -34.6 13.84 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.65 2.233 . . . . 64.24 112.339 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.2 120.43 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.102 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.76 163.12 14.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 75.55 110.974 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -123.88 -57.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.02 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.5 174.78 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.17 160.53 78.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.581 0.705 . . . . 72.41 110.872 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 170.17 17.16 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.669 2.246 . . . . 62.03 112.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.56 -51.51 4.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.738 . . . . 63.45 112.505 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -64.83 147.68 52.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 70.54 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 p -83.66 143.34 30.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.137 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t -87.24 149.7 24.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.55 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -135.48 138.74 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.52 110.896 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 ttp85 -105.09 37.79 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.889 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.98 -78.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 71.24 112.481 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.5 mt -52.56 164.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 55.55 110.912 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -35.72 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.868 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.59 140.65 15.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.481 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -52.02 123.91 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 75.54 110.926 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.62 171.77 21.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.713 -0.756 . . . . 43.42 112.48 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -105.71 129.59 53.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 73.51 110.861 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 55.23 110.89 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.686 0.755 . . . . 73.32 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 84.68 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 74.43 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -114.31 73.43 2.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.732 . . . . 71.23 110.879 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -33.15 17.28 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 45.13 112.352 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -67.6 146.59 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.32 111.117 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.14 98.13 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 64.13 110.925 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.33 -51.19 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 64.13 111.162 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.57 171.44 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 51.53 110.837 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -91.06 159.01 40.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.624 0.726 . . . . 63.43 110.854 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.52 16.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.652 2.235 . . . . 74.21 112.326 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.46 -49.5 3.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 71.22 112.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.66 144.71 57.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.44 110.892 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -84.51 144.71 28.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.42 111.146 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.5 t -79.33 140.98 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 72.5 110.834 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 p -119.45 147.45 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 72.21 110.88 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -102.03 133.75 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.886 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.89 -89.44 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 71.02 112.477 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.02 165.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 71.45 110.896 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -49.12 -34.26 13.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 65.33 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.66 149.97 17.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.696 -0.764 . . . . 60.45 112.491 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -51.55 132.69 30.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 74.02 110.911 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.4 165.63 12.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.69 -0.767 . . . . 72.44 112.478 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.6 p -120.06 113.02 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.25 110.921 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.879 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.643 0.735 . . . . 72.42 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -46.43 1.26 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 73.31 112.385 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -145.44 68.44 13.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 74.41 110.865 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 176.5 6.68 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.655 2.236 . . . . 73.41 112.388 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.66 147.06 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 73.52 111.161 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.35 98.16 8.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.948 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -135.77 -41.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 70.33 111.106 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.04 -179.86 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 72.03 110.858 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -95.29 159.3 33.14 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.565 0.697 . . . . 61.21 110.878 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 163.07 39.66 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.688 2.259 . . . . 75.21 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -45.8 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 71.15 112.48 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.18 144.54 57.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 54.2 110.923 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -94.2 144.94 25.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 62.03 111.178 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 t -79.17 133.2 36.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.14 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.99 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 43.31 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttp85 -102.6 41.81 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.57 -78.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 71.25 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.77 165.14 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 73.14 110.883 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -49.8 -34.55 19.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 54.2 110.837 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.43 141.51 15.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 44.32 112.483 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.67 126.36 17.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.944 0.402 . . . . 75.41 110.88 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.06 167.56 18.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 65.13 112.463 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 p -121.52 119.72 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 63.32 110.875 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.883 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.688 0.756 . . . . 65.54 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 133.93 26.93 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 75.32 112.357 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.61 160.14 48.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 73.41 110.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -39.9 5.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 54.3 112.33 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.82 112.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.54 111.101 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -84.93 100.53 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.52 110.922 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -125.86 -42.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 75.33 111.154 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.57 178.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.867 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.85 157.61 59.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.578 0.704 . . . . 74.31 110.877 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 162.57 41.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.649 2.233 . . . . 73.13 112.33 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.59 3.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 52.13 112.483 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -64.67 143.53 57.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.878 0.371 . . . . 62.11 110.907 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 t -83.79 139.18 32.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.12 136.67 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.4 110.855 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.06 151.33 50.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.892 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 37.06 3.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 64.35 110.862 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.84 -82.56 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 53.22 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 164.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.375 . . . . 71.23 110.9 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -50.45 -34.96 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.14 142.14 15.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.667 -0.778 . . . . 71.21 112.458 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.55 133.9 52.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 74.33 110.954 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.91 175.44 29.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 73.1 112.464 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.0 p -114.98 122.02 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 70.52 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.86 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.629 0.728 . . . . 74.33 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -33.58 16.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.64 2.226 . . . . 74.4 112.325 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.02 160.52 78.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 61.51 110.839 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -42.48 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.236 . . . . 75.32 112.312 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.41 145.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 65.1 111.095 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -129.73 104.75 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 72.33 110.923 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -111.33 -35.78 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 53.44 111.128 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.36 168.56 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 63.52 110.935 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -83.85 159.15 61.01 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.71 . . . . 74.44 110.892 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 169.77 18.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 74.34 112.323 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.56 -50.29 4.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 62.52 112.53 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -64.66 152.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 71.45 110.92 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 t -88.59 144.63 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.45 111.11 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.73 132.77 34.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 62.1 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.9 p -113.29 143.85 43.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.01 110.887 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -110.34 51.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.825 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.08 -78.74 1.15 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 63.35 112.484 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -51.62 165.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 74.04 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -49.07 -34.27 13.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 73.05 110.85 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.51 -172.25 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 60.24 112.485 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -89.69 127.7 35.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 71.03 110.902 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.24 175.35 19.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 72.3 112.458 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 p -119.14 124.71 47.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.367 . . . . 61.04 110.852 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.838 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.666 0.746 . . . . 65.5 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -37.53 9.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.252 . . . . 72.44 112.376 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.21 68.16 0.2 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 62.41 110.834 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 73.31 112.364 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.26 150.22 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.142 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 98.1 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.94 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.53 -52.89 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 62.1 111.105 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 m -67.49 169.74 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 42.31 110.878 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 155.86 67.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 73.34 110.909 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 155.95 64.46 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.722 2.282 . . . . 73.14 112.317 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.54 -48.89 3.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.511 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.45 129.93 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 75.22 110.899 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -85.82 144.78 27.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.148 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -79.25 131.9 36.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 64.35 110.907 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.11 153.78 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 51.24 110.862 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -107.92 40.58 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.1 110.836 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.28 -81.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 72.33 112.471 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.86 164.84 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 73.12 110.86 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -50.73 -35.12 29.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.894 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.39 144.69 15.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.483 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -51.86 127.39 20.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 62.23 110.938 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.93 175.54 21.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 71.22 112.491 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.83 123.32 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 70.21 110.893 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 70.04 110.865 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.609 0.719 . . . . 44.32 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.259 . . . . 65.34 112.356 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -117.65 68.68 6.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 71.12 110.857 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 54.24 112.351 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.91 149.89 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.24 111.092 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.11 98.4 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.933 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -130.55 -49.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 70.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.21 -174.36 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 157.61 50.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 72.44 110.854 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.89 26.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 71.03 112.319 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 -49.85 4.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 41.22 112.49 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -64.84 144.95 56.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.914 0.388 . . . . 71.33 110.861 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -85.19 144.57 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.23 111.151 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -79.38 140.42 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.861 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.17 138.65 51.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.891 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -109.9 54.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.76 1.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 52.42 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.6 165.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 74.43 110.937 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -49.41 -34.47 16.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.02 110.828 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.17 -174.77 31.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 71.14 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.7 129.41 36.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.925 0.393 . . . . 75.33 110.909 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.22 168.7 20.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 72.04 112.525 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -117.86 115.59 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 64.33 110.905 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 31.25 110.871 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.651 0.738 . . . . 54.14 110.859 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -33.43 16.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.727 2.285 . . . . 60.44 112.314 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.99 160.49 1.15 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.644 0.735 . . . . 75.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.656 2.238 . . . . 74.25 112.337 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.34 148.91 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.098 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.44 102.81 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.926 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -52.3 -36.55 53.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.33 111.186 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.27 179.68 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 34.01 110.872 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.56 69.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.542 0.687 . . . . 75.12 110.917 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 161.51 45.62 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 72.4 112.373 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.37 -49.53 3.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 54.31 112.465 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -65.42 143.84 57.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 75.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -86.66 136.57 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.108 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -83.19 131.74 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 63.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.23 156.15 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.45 51.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.897 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.43 -32.9 36.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 71.21 112.506 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.26 165.55 11.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -48.05 -34.32 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.84 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.15 138.22 14.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 63.14 112.478 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -52.05 128.88 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 64.22 110.905 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.0 175.55 21.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 73.22 112.461 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.3 p -114.04 129.29 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 51.03 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.4 110.894 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.61 0.719 . . . . 73.34 110.836 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.625 2.216 . . . . 74.55 112.311 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.04 160.54 27.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 72.25 110.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -33.05 17.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.698 2.265 . . . . 62.13 112.357 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.38 149.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 54.31 111.148 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -71.72 99.75 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 75.45 110.888 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -110.86 -39.58 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.516 . . . . 75.41 111.155 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 89.6 m -74.33 -175.22 2.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.851 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -111.25 157.24 39.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 73.24 110.879 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 160.81 48.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.258 . . . . 64.14 112.341 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 -48.99 3.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 70.24 112.494 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.65 149.06 49.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 71.33 110.902 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 62.44 111.195 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -79.1 129.09 34.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 74.45 110.888 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.13 161.19 22.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 34.03 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.19 47.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.876 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.65 -88.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 54.41 112.526 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.55 165.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.792 0.329 . . . . 71.31 110.961 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -49.06 -34.37 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.05 110.846 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.65 17.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 63.43 112.471 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -51.89 130.09 28.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 72.11 110.93 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.15 166.08 24.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.505 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.4 p -119.9 113.05 19.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 24.4 110.873 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 61.02 110.846 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.661 0.744 . . . . 45.34 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.25 16.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.719 2.279 . . . . 73.15 112.361 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.97 160.57 1.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.561 0.696 . . . . 53.54 110.88 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.84 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 62.04 112.36 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.37 143.41 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -120.34 163.69 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 71.22 110.922 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -51.79 -35.84 45.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 62.11 111.173 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.2 m -52.94 169.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 51.21 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -93.64 159.22 35.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 65.24 110.838 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.99 10.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 75.42 112.32 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -50.48 4.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 53.54 112.47 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -64.64 149.84 48.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.42 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -82.64 142.42 31.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.52 111.121 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -82.43 132.85 35.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 71.44 110.888 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.76 143.16 45.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.873 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -109.44 37.2 2.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.44 110.9 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 32.04 112.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -51.94 164.47 0.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 73.13 110.933 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.97 -35.93 47.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 71.03 110.863 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 138.54 14.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 64.35 112.53 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -52.34 129.27 27.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.915 0.388 . . . . 75.04 110.886 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.92 175.04 21.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 62.41 112.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.9 p -104.93 136.97 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 72.53 110.888 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 71.51 110.863 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.616 0.722 . . . . 64.11 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.88 17.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 70.24 112.346 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -173.14 65.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 62.22 110.844 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.675 2.25 . . . . 72.35 112.344 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' VAL . 8.3 m -101.77 107.39 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.31 111.144 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -130.84 164.04 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.04 110.886 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.3 p -51.69 -34.54 38.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.107 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.44 -171.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -111.02 160.97 26.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.616 0.722 . . . . 75.22 110.847 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 64.52 112.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.78 -45.88 3.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 41.22 112.479 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.13 152.2 41.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.396 . . . . 73.12 110.901 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 t -81.39 144.82 31.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 72.14 111.15 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.4 t -79.41 140.43 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.12 110.906 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.16 136.63 53.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 42.54 110.933 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.25 35.64 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.3 110.892 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.62 -64.23 3.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 60.41 112.466 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.92 165.08 25.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 74.35 110.917 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -49.75 -34.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.87 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.91 140.72 16.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 42.31 112.511 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -51.54 133.05 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.399 . . . . 73.42 110.901 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.66 175.61 20.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 51.21 112.508 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -98.38 129.81 45.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 65.31 110.881 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 64.22 110.865 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.665 0.745 . . . . 74.22 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 79.12 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 64.41 112.353 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -116.77 73.41 6.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.71 . . . . 54.52 110.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.15 17.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.25 . . . . 61.52 112.361 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.95 145.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -72.4 103.91 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.941 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -118.34 -47.18 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 54.32 111.096 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 m -113.21 171.17 7.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 64.42 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.63 160.57 50.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 72.25 110.902 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.21 28.35 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.673 2.249 . . . . 74.02 112.38 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.48 -49.55 3.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.72 . . . . 74.22 112.493 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.34 143.58 56.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.927 0.394 . . . . 71.31 110.9 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -87.54 136.64 32.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.172 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.66 132.51 35.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 64.2 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -126.52 147.33 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.919 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -105.11 35.8 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.08 -80.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 71.12 112.511 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -51.94 164.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 64.35 110.939 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -51.09 -35.17 33.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 63.5 110.88 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.58 139.5 14.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 62.41 112.488 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -51.92 130.06 28.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 71.31 110.923 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.18 175.39 26.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 31.45 112.499 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -114.47 133.15 55.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 53.25 110.929 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 60.13 110.847 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.607 0.717 . . . . 74.31 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -34.26 15.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.704 2.27 . . . . 72.41 112.35 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.76 160.71 1.02 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.43 110.902 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 77.99 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.747 2.298 . . . . 70.12 112.323 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 21' ' ' TYR . 17.9 m -101.64 150.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.121 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.15 98.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.94 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -51.66 126.12 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 71.41 111.113 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 m -89.68 -169.54 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.34 110.853 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -60.76 160.6 18.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.633 0.73 . . . . 72.51 110.861 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.84 55.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 73.4 112.338 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 -47.64 3.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 72.41 112.471 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.32 151.95 42.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.352 . . . . 62.51 110.919 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -108.54 145.16 35.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.22 111.132 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.3 t -78.81 114.14 17.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 44.32 110.906 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.96 161.18 14.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 53.23 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -123.6 143.38 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.867 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.95 -32.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 33.12 112.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 166.29 10.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.355 . . . . 75.5 110.877 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -46.5 -34.64 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 65.24 110.845 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.26 14.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 62.24 112.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 5' ' ' VAL . 11.7 m-85 -51.67 142.14 15.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 70.44 110.916 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.04 169.48 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 30.42 112.48 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 p -125.12 112.94 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.876 0.369 . . . . 72.41 110.899 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.883 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.593 0.711 . . . . 61.33 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.56 18.15 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.223 . . . . 74.43 112.378 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.19 158.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.617 0.722 . . . . 74.53 110.861 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 165.98 29.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.682 2.255 . . . . 63.02 112.361 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.7 p -55.25 122.95 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.02 111.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -119.26 143.79 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 71.22 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -53.44 123.25 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.145 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.23 175.77 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.926 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -107.22 157.65 34.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.657 0.741 . . . . 74.54 110.812 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 158.26 57.58 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.698 2.265 . . . . 54.11 112.321 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -48.09 3.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 23.0 112.549 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.49 127.27 30.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 75.25 110.888 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -83.62 145.05 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 62.12 111.167 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.2 t -78.96 114.12 17.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 p -121.66 170.34 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 64.24 110.919 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.22 33.63 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.863 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.31 -70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 71.14 112.472 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.6 mt -58.72 165.03 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 74.14 110.918 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -50.15 -34.74 23.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.833 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.89 138.49 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 63.43 112.434 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -51.86 129.78 27.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 74.2 110.908 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.07 175.58 29.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 74.4 112.503 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.8 p -106.1 127.93 53.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.12 110.845 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 51.35 110.83 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.652 0.739 . . . . 31.03 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -40.57 5.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 53.15 112.335 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.11 160.56 2.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.595 0.712 . . . . 65.54 110.854 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -44.05 2.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.687 2.258 . . . . 64.25 112.389 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.31 133.23 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 44.35 111.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -102.24 125.9 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 71.03 110.935 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -84.16 -36.04 23.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 63.34 111.169 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.45 179.71 4.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.1 110.875 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -66.76 160.63 67.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 71.45 110.888 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 157.07 61.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 61.42 112.305 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.57 3.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 62.0 112.49 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -64.62 140.34 58.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 60.54 110.922 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -87.73 144.55 26.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 75.53 111.09 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -88.99 127.53 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.888 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -120.8 141.98 50.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 44.51 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -99.56 35.6 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.42 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.5 -81.43 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.762 . . . . 41.55 112.47 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -51.91 164.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.793 0.33 . . . . 74.03 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -51.23 -35.43 36.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 72.41 110.852 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.05 140.42 15.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 63.1 112.508 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -51.83 126.24 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 71.43 110.985 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.2 175.52 20.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 73.14 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.36 115.34 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 63.23 110.904 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 75.1 110.836 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.629 0.728 . . . . 72.43 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 91.67 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.664 2.243 . . . . 72.54 112.364 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -133.47 160.58 68.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.591 0.71 . . . . 62.21 110.917 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -44.94 1.79 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.728 2.285 . . . . 72.11 112.337 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.05 134.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 62.15 111.122 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -90.64 142.51 27.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.489 . . . . 73.43 110.932 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -110.02 -64.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 51.24 111.152 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 m -81.74 179.2 7.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.11 110.839 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -77.5 160.6 74.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 71.55 110.861 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.94 51.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.678 2.252 . . . . 61.24 112.359 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -49.59 3.91 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 73.5 112.455 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -65.12 149.57 49.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 74.3 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -90.39 137.05 32.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 65.11 111.165 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.1 127.92 35.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.9 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -123.87 149.98 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.62 38.49 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.894 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.33 -64.59 2.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.732 -0.746 . . . . 53.24 112.49 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.97 164.73 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.899 0.381 . . . . 74.34 110.898 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -51.18 -35.38 35.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.869 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.53 138.43 14.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 64.14 112.492 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.0 127.79 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 73.33 110.931 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.99 175.4 27.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.756 -0.735 . . . . 75.44 112.508 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 p -112.63 127.62 56.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 65.33 110.879 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.887 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 63.41 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 145.16 56.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.255 . . . . 41.13 112.323 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.27 160.08 1.18 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 74.31 110.85 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -43.33 2.7 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.678 2.252 . . . . 62.4 112.334 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -75.06 149.18 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.42 111.095 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -72.06 114.96 10.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 61.25 110.936 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -70.24 177.71 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 53.45 111.138 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.0 m -70.94 -175.28 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 45.21 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -61.4 160.6 23.35 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.573 0.701 . . . . 75.53 110.904 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 169.58 18.54 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.725 2.283 . . . . 72.53 112.373 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -50.35 4.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 43.15 112.512 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.96 151.59 45.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 74.41 110.946 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 t -82.87 143.87 30.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t -94.04 148.12 22.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 41.01 110.851 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.2 p -130.49 141.78 50.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.91 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -111.1 37.74 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.31 110.888 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 -77.75 0.54 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.725 -0.75 . . . . 45.12 112.491 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -51.95 164.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 73.24 110.893 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -51.97 -35.92 47.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 74.51 110.873 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.95 138.7 14.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 52.13 112.509 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -52.91 132.36 37.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 72.4 110.913 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.82 170.19 25.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 41.14 112.499 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.6 p -99.19 140.52 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 52.21 110.889 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 65.23 110.822 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.624 0.726 . . . . 64.11 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -33.23 17.14 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.662 2.241 . . . . 72.11 112.343 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 5' ' ' VAL . 6.6 m-20 -51.97 160.59 1.12 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 75.45 110.919 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -33.12 17.26 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.725 2.283 . . . . 71.32 112.327 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 3' ' ' ASP . 17.5 m -55.36 121.72 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 63.12 111.095 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.5 123.68 49.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.912 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -100.96 -37.99 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 51.21 111.144 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -120.8 175.11 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 63.34 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -63.35 159.1 52.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.741 . . . . 74.33 110.85 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 167.9 23.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.654 2.236 . . . . 71.22 112.346 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.51 -51.31 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 60.02 112.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.67 144.62 57.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 53.04 110.89 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -82.29 144.56 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 71.23 111.166 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.55 117.92 27.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.918 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.1 p -98.92 139.35 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -100.31 35.74 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.41 -82.65 0.16 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 73.14 112.471 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.4 mt -51.88 164.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 64.23 110.911 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -51.47 -35.5 40.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.864 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.63 140.79 15.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 51.33 112.469 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -52.0 125.0 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.932 0.396 . . . . 75.24 110.951 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.3 175.47 20.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 44.43 112.496 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.9 p -106.57 132.73 52.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 63.43 110.85 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.883 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.616 0.722 . . . . 71.54 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 82.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.25 . . . . 75.4 112.355 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.0 160.52 30.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 61.54 110.87 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -48.37 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.723 2.282 . . . . 62.23 112.335 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.49 150.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.34 111.133 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.0 107.92 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 71.1 110.912 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -96.81 -37.26 10.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 62.41 111.144 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.3 m -106.73 179.5 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.879 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -97.83 160.54 28.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 60.25 110.863 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 163.38 38.44 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.68 2.253 . . . . 64.11 112.388 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 -49.45 3.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 71.31 112.492 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -65.55 136.1 55.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 64.44 110.919 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -83.01 139.84 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t -79.43 114.21 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 75.51 110.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -97.32 143.84 27.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.885 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -103.98 38.85 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.859 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.47 -82.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.486 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.4 mp -51.88 164.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.42 110.949 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -51.57 -35.62 41.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.827 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.2 138.64 14.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.479 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -51.96 123.32 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 73.44 110.924 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.22 175.51 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 75.4 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 p -114.69 121.02 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 74.24 110.858 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 52.24 110.912 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.627 0.727 . . . . 50.35 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 95.89 0.57 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.701 2.268 . . . . 72.13 112.328 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.54 160.04 1.11 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.568 0.699 . . . . 72.05 110.903 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -48.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.246 . . . . 71.13 112.317 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -101.51 150.14 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.55 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -97.62 160.47 14.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.918 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -118.18 -66.11 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 64.11 111.138 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 m -60.85 -179.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.14 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -74.09 160.56 81.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 73.24 110.85 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 159.31 53.9 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.702 2.268 . . . . 64.04 112.304 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.02 -51.27 4.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 52.03 112.432 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.59 128.76 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 61.44 110.899 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.3 t -81.51 144.7 31.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.32 111.12 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -83.89 119.02 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.12 110.918 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 p -106.66 153.75 21.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 52.45 110.854 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 35.74 3.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 64.34 110.831 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.1 -74.26 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 72.14 112.47 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.09 164.59 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 73.51 110.932 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -51.54 -35.65 41.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 71.05 110.874 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.25 138.51 14.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 70.13 112.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -52.01 130.57 30.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 64.43 110.899 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.08 175.49 30.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 51.32 112.49 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -106.14 134.42 49.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 73.31 110.933 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.887 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.612 0.72 . . . . 63.22 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.01 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.634 2.222 . . . . 74.43 112.373 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.54 158.53 1.46 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.576 0.703 . . . . 73.14 110.87 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 -34.6 13.84 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.65 2.233 . . . . 64.24 112.339 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.2 120.43 10.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.102 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.76 163.12 14.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 75.55 110.974 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -123.88 -57.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.02 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.5 174.78 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.17 160.53 78.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.581 0.705 . . . . 72.41 110.872 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 170.17 17.16 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.669 2.246 . . . . 62.03 112.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.56 -51.51 4.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.751 -0.738 . . . . 63.45 112.505 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -64.83 147.68 52.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 70.54 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 p -83.66 143.34 30.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.137 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t -87.24 149.7 24.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.55 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -135.48 138.74 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.52 110.896 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.3 ttp85 -105.09 37.79 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.889 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.98 -78.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 71.24 112.481 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.5 mt -52.56 164.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 55.55 110.912 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -35.72 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.868 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.59 140.65 15.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.481 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -52.02 123.91 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 75.54 110.926 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.62 171.77 21.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.713 -0.756 . . . . 43.42 112.48 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -105.71 129.59 53.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 73.51 110.861 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 55.23 110.89 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 121.686 0.755 . . . . 73.32 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 84.68 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 74.43 112.316 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -114.31 73.43 2.66 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.638 0.732 . . . . 71.23 110.879 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -33.15 17.28 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.682 2.255 . . . . 45.13 112.352 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -67.6 146.59 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.32 111.117 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -74.14 98.13 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 64.13 110.925 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.33 -51.19 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 64.13 111.162 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.0 m -121.57 171.44 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 51.53 110.837 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -91.06 159.01 40.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.624 0.726 . . . . 63.43 110.854 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.52 16.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.652 2.235 . . . . 74.21 112.326 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.46 -49.5 3.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 71.22 112.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.66 144.71 57.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.44 110.892 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -84.51 144.71 28.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.42 111.146 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.5 t -79.33 140.98 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 72.5 110.834 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 p -119.45 147.45 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 72.21 110.88 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -102.03 133.75 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.886 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.89 -89.44 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 71.02 112.477 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.02 165.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 71.45 110.896 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -49.12 -34.26 13.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 65.33 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.66 149.97 17.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.696 -0.764 . . . . 60.45 112.491 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -51.55 132.69 30.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 74.02 110.911 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.4 165.63 12.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.69 -0.767 . . . . 72.44 112.478 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.6 p -120.06 113.02 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.25 110.921 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.879 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.643 0.735 . . . . 72.42 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -46.43 1.26 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 73.31 112.385 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -145.44 68.44 13.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 74.41 110.865 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 176.5 6.68 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.655 2.236 . . . . 73.41 112.388 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.66 147.06 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 73.52 111.161 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -82.35 98.16 8.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.948 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -135.77 -41.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 70.33 111.106 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.04 -179.86 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 72.03 110.858 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -95.29 159.3 33.14 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.565 0.697 . . . . 61.21 110.878 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 163.07 39.66 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.688 2.259 . . . . 75.21 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 -45.8 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 71.15 112.48 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -64.18 144.54 57.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 54.2 110.923 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -94.2 144.94 25.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 62.03 111.178 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 t -79.17 133.2 36.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.14 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.99 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 43.31 110.908 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttp85 -102.6 41.81 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.57 -78.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 71.25 112.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.77 165.14 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 73.14 110.883 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -49.8 -34.55 19.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 54.2 110.837 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.43 141.51 15.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 44.32 112.483 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -51.67 126.36 17.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.944 0.402 . . . . 75.41 110.88 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.06 167.56 18.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 65.13 112.463 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 p -121.52 119.72 32.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 63.32 110.875 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.883 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.688 0.756 . . . . 65.54 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 133.93 26.93 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 75.32 112.357 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.61 160.14 48.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 73.41 110.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -39.9 5.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 54.3 112.33 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.82 112.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.54 111.101 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -84.93 100.53 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 72.52 110.922 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -125.86 -42.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 75.33 111.154 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.57 178.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.867 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.85 157.61 59.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.578 0.704 . . . . 74.31 110.877 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 162.57 41.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.649 2.233 . . . . 73.13 112.33 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.59 3.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 52.13 112.483 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -64.67 143.53 57.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.878 0.371 . . . . 62.11 110.907 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 t -83.79 139.18 32.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -83.12 136.67 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.4 110.855 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.06 151.33 50.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.892 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.19 37.06 3.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 64.35 110.862 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.84 -82.56 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 53.22 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.97 164.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.375 . . . . 71.23 110.9 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -50.45 -34.96 26.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.14 142.14 15.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.667 -0.778 . . . . 71.21 112.458 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.55 133.9 52.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 74.33 110.954 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.91 175.44 29.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 73.1 112.464 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.0 p -114.98 122.02 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 70.52 110.862 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.86 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.629 0.728 . . . . 74.33 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -33.58 16.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.64 2.226 . . . . 74.4 112.325 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.02 160.52 78.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 61.51 110.839 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -42.48 3.4 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.236 . . . . 75.32 112.312 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -55.41 145.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 65.1 111.095 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -129.73 104.75 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 72.33 110.923 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -111.33 -35.78 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 53.44 111.128 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.36 168.56 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 63.52 110.935 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -83.85 159.15 61.01 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.71 . . . . 74.44 110.892 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 169.77 18.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 74.34 112.323 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.56 -50.29 4.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 62.52 112.53 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -64.66 152.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 71.45 110.92 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 t -88.59 144.63 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.45 111.11 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.73 132.77 34.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 62.1 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.9 p -113.29 143.85 43.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.01 110.887 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -110.34 51.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.825 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.08 -78.74 1.15 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 63.35 112.484 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -51.62 165.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 74.04 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -49.07 -34.27 13.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 73.05 110.85 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.51 -172.25 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 60.24 112.485 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -89.69 127.7 35.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 71.03 110.902 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.24 175.35 19.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 72.3 112.458 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 p -119.14 124.71 47.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.367 . . . . 61.04 110.852 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.838 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.666 0.746 . . . . 65.5 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -37.53 9.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.252 . . . . 72.44 112.376 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.21 68.16 0.2 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 62.41 110.834 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 73.31 112.364 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.26 150.22 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.142 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 98.1 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.94 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.53 -52.89 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 62.1 111.105 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 m -67.49 169.74 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 42.31 110.878 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 155.86 67.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 73.34 110.909 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 155.95 64.46 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.722 2.282 . . . . 73.14 112.317 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.54 -48.89 3.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.511 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.45 129.93 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 75.22 110.899 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -85.82 144.78 27.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.148 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -79.25 131.9 36.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 64.35 110.907 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.11 153.78 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 51.24 110.862 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -107.92 40.58 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.1 110.836 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.28 -81.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 72.33 112.471 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.86 164.84 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 73.12 110.86 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -50.73 -35.12 29.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.894 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.39 144.69 15.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.483 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -51.86 127.39 20.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 62.23 110.938 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.93 175.54 21.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 71.22 112.491 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.83 123.32 44.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 70.21 110.893 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 70.04 110.865 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.609 0.719 . . . . 44.32 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.259 . . . . 65.34 112.356 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -117.65 68.68 6.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 71.12 110.857 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 54.24 112.351 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.91 149.89 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.24 111.092 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -78.11 98.4 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.933 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -130.55 -49.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 70.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.21 -174.36 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 157.61 50.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 72.44 110.854 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.89 26.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 71.03 112.319 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 -49.85 4.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 41.22 112.49 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -64.84 144.95 56.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.914 0.388 . . . . 71.33 110.861 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -85.19 144.57 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.23 111.151 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -79.38 140.42 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.861 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.17 138.65 51.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.891 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -109.9 54.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.904 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.76 1.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.718 -0.753 . . . . 52.42 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.6 165.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 74.43 110.937 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -49.41 -34.47 16.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.02 110.828 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.17 -174.77 31.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.73 . . . . 71.14 112.472 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -89.7 129.41 36.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.925 0.393 . . . . 75.33 110.909 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.22 168.7 20.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 72.04 112.525 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -117.86 115.59 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 64.33 110.905 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 31.25 110.871 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.651 0.738 . . . . 54.14 110.859 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -33.43 16.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.727 2.285 . . . . 60.44 112.314 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.99 160.49 1.15 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.644 0.735 . . . . 75.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.656 2.238 . . . . 74.25 112.337 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.34 148.91 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.098 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -110.44 102.81 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 73.55 110.926 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -52.3 -36.55 53.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.33 111.186 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.27 179.68 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 34.01 110.872 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.56 69.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.542 0.687 . . . . 75.12 110.917 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 161.51 45.62 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 72.4 112.373 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.37 -49.53 3.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 54.31 112.465 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -65.42 143.84 57.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 75.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -86.66 136.57 32.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.108 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -83.19 131.74 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 63.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.23 156.15 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.45 51.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.897 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.43 -32.9 36.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 71.21 112.506 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.26 165.55 11.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.0 110.91 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -48.05 -34.32 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.84 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.15 138.22 14.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 63.14 112.478 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -52.05 128.88 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 64.22 110.905 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.0 175.55 21.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 73.22 112.461 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.3 p -114.04 129.29 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 51.03 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.4 110.894 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.61 0.719 . . . . 73.34 110.836 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.625 2.216 . . . . 74.55 112.311 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.04 160.54 27.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 72.25 110.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -33.05 17.46 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.698 2.265 . . . . 62.13 112.357 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.38 149.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 54.31 111.148 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -71.72 99.75 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 75.45 110.888 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -110.86 -39.58 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.516 . . . . 75.41 111.155 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 89.6 m -74.33 -175.22 2.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.851 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -111.25 157.24 39.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 73.24 110.879 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 160.81 48.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.258 . . . . 64.14 112.341 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.51 -48.99 3.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 70.24 112.494 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.65 149.06 49.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 71.33 110.902 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 62.44 111.195 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -79.1 129.09 34.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 74.45 110.888 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.13 161.19 22.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 34.03 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.19 47.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.876 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.65 -88.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 54.41 112.526 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.55 165.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.792 0.329 . . . . 71.31 110.961 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -49.06 -34.37 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.05 110.846 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.65 17.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.753 -0.737 . . . . 63.43 112.471 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -51.89 130.09 28.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 72.11 110.93 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.15 166.08 24.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.505 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.4 p -119.9 113.05 19.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 24.4 110.873 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 61.02 110.846 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.661 0.744 . . . . 45.34 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -33.25 16.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.719 2.279 . . . . 73.15 112.361 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.97 160.57 1.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.561 0.696 . . . . 53.54 110.88 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -172.84 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 62.04 112.36 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.37 143.41 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -120.34 163.69 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 71.22 110.922 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -51.79 -35.84 45.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 62.11 111.173 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.2 m -52.94 169.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 51.21 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -93.64 159.22 35.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.739 . . . . 65.24 110.838 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.99 10.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 75.42 112.32 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -50.48 4.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 53.54 112.47 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -64.64 149.84 48.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.42 110.911 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -82.64 142.42 31.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.52 111.121 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -82.43 132.85 35.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 71.44 110.888 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.76 143.16 45.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.873 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -109.44 37.2 2.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.44 110.9 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.25 -81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 32.04 112.456 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -51.94 164.47 0.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 73.13 110.933 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.97 -35.93 47.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 71.03 110.863 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 138.54 14.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 64.35 112.53 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -52.34 129.27 27.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.915 0.388 . . . . 75.04 110.886 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.92 175.04 21.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 62.41 112.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.9 p -104.93 136.97 43.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 72.53 110.888 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 71.51 110.863 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.616 0.722 . . . . 64.11 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.88 17.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 70.24 112.346 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -173.14 65.97 0.34 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 62.22 110.844 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.675 2.25 . . . . 72.35 112.344 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' VAL . 8.3 m -101.77 107.39 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.31 111.144 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -130.84 164.04 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.04 110.886 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.3 p -51.69 -34.54 38.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.077 -0.51 . . . . 74.34 111.107 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 m -60.44 -171.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 mtt85 -111.02 160.97 26.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.616 0.722 . . . . 75.22 110.847 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 64.52 112.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.78 -45.88 3.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 41.22 112.479 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.13 152.2 41.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.396 . . . . 73.12 110.901 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 t -81.39 144.82 31.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 72.14 111.15 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.4 t -79.41 140.43 37.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 65.12 110.906 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 p -125.16 136.63 53.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 42.54 110.933 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.25 35.64 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.3 110.892 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.62 -64.23 3.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 60.41 112.466 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.92 165.08 25.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.839 0.352 . . . . 74.35 110.917 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -49.75 -34.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.87 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.91 140.72 16.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 42.31 112.511 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -51.54 133.05 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.399 . . . . 73.42 110.901 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.66 175.61 20.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 51.21 112.508 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -98.38 129.81 45.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 65.31 110.881 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 64.22 110.865 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.665 0.745 . . . . 74.22 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 79.12 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.665 2.243 . . . . 64.41 112.353 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -116.77 73.41 6.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.71 . . . . 54.52 110.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.15 17.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.25 . . . . 61.52 112.361 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.95 145.46 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -72.4 103.91 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.941 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -118.34 -47.18 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 54.32 111.096 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 m -113.21 171.17 7.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 64.42 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.63 160.57 50.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 72.25 110.902 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.21 28.35 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.673 2.249 . . . . 74.02 112.38 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.48 -49.55 3.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.72 . . . . 74.22 112.493 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -67.34 143.58 56.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.927 0.394 . . . . 71.31 110.9 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -87.54 136.64 32.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.172 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.66 132.51 35.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 64.2 110.826 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 p -126.52 147.33 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.919 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -105.11 35.8 2.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.08 -80.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.776 -0.726 . . . . 71.12 112.511 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -51.94 164.76 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 64.35 110.939 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -51.09 -35.17 33.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 63.5 110.88 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.58 139.5 14.88 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.708 -0.758 . . . . 62.41 112.488 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -51.92 130.06 28.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.919 0.39 . . . . 71.31 110.923 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.18 175.39 26.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 31.45 112.499 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -114.47 133.15 55.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 53.25 110.929 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 60.13 110.847 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.607 0.717 . . . . 74.31 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -34.26 15.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.704 2.27 . . . . 72.41 112.35 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.76 160.71 1.02 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 72.43 110.902 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 77.99 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.747 2.298 . . . . 70.12 112.323 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 21' ' ' TYR . 17.9 m -101.64 150.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.121 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.15 98.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.94 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -51.66 126.12 16.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 71.41 111.113 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 m -89.68 -169.54 2.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.34 110.853 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -60.76 160.6 18.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.633 0.73 . . . . 72.51 110.861 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.84 55.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 73.4 112.338 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 -47.64 3.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 72.41 112.471 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.32 151.95 42.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.352 . . . . 62.51 110.919 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -108.54 145.16 35.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 62.22 111.132 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.3 t -78.81 114.14 17.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 44.32 110.906 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.96 161.18 14.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 53.23 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -123.6 143.38 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.867 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.95 -32.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 33.12 112.485 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.24 166.29 10.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.355 . . . . 75.5 110.877 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -46.5 -34.64 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 65.24 110.845 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.26 14.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 62.24 112.485 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 5' ' ' VAL . 11.7 m-85 -51.67 142.14 15.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 70.44 110.916 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.04 169.48 21.63 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 30.42 112.48 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 p -125.12 112.94 17.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.876 0.369 . . . . 72.41 110.899 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.883 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.593 0.711 . . . . 61.33 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.56 18.15 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.223 . . . . 74.43 112.378 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.19 158.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.617 0.722 . . . . 74.53 110.861 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 165.98 29.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.682 2.255 . . . . 63.02 112.361 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.7 p -55.25 122.95 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.02 111.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -119.26 143.79 47.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 71.22 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -53.44 123.25 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.145 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.23 175.77 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.926 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -107.22 157.65 34.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.657 0.741 . . . . 74.54 110.812 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 158.26 57.58 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.698 2.265 . . . . 54.11 112.321 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.52 -48.09 3.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 23.0 112.549 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.49 127.27 30.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 75.25 110.888 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -83.62 145.05 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 62.12 111.167 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.2 t -78.96 114.12 17.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 p -121.66 170.34 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 64.24 110.919 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.22 33.63 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.863 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.31 -70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 71.14 112.472 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.6 mt -58.72 165.03 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 74.14 110.918 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -50.15 -34.74 23.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.833 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.89 138.49 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 63.43 112.434 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -51.86 129.78 27.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 74.2 110.908 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.07 175.58 29.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 74.4 112.503 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 23.8 p -106.1 127.93 53.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.12 110.845 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 51.35 110.83 -179.978 . . . . . . . . 0 0 . 1 stop_ save_